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The identification of factors underlying complex trait variation is a major goal in
the field of genetics. For normally distributed, fully observed trait data there are
many well established statistical methods for partitioning phenotypic variation
and for mapping quantitative trait loci (QTL). Survival or time-to-event traits
often follow non-normal distributions and frequently contain partially-known
(or censored) trait data. If standard statistical methods are used to analyse
age at onset data a bias can be introduced through a failure to account for the
non-normal distribution of the data and the presence of censoring. Complex
statistical methods have been developed to partition trait variation and map
QTL for age at onset or survival traits. In this thesis, the use of these survival
analysis methods is compared to more established statistical methods for the
analysis of age-at-onset data.
A brief introduction to the analysis of human variation and the issues associated
with the analysis of age at onset data is given. The methods currently used to
partition trait variation and map QTL for survival traits are discussed (Chapter
1). Age-specific penetrances can be used to model the age-at-onset of disease
in unaffected individuals. This parametric method is used to identify loci
underlying susceptibility to a novel co-morbid psychiatric phenotype (depression
and unexplained swelling). The method is compared to a non-parametric
variance component (VC) QTL mapping method that does not account for the
age at onset of the disease. Parametric linkage analysis identified two suggestive
v
loci, neither of which were supported by the standard variance component
analysis. VC analysis identified a suggestive linkage region on chromosome 14
which decreased upon fine mapping (Chapter 2).
Many of the current methods used to analyse survival data in human genetics
are based on methods originally derived by animal geneticists. The analysis of
survival traits in some experimental populations is simplified by the presence
of fully inbred lines. However, for complex traits the methods are both
computationally intensive and not widely available. A grouped linear regression
method is proposed for the analysis of continuous survival data in fully inbred
lines. Using simulation the method is compared to both the Cox and Weibull
proportional hazards models and a standard linear regression method that
ignores censoring. The grouped linear regression method is of equivalent power
to both the Cox and Weibull proportional hazards methods, is significantly
better than the standard linear regression method when censored observations
are present and is computationally simple (Chapter 3).
A sample of 446 monozygotic (MZ) twins, 633 dizygotic (DZ) twins and 223
siblings was used to partition the inter-individual variance in age at menarche.
The analysis was carried out using both a standard method which failed to
account for the censored nature of the data and a mixed effects Cox model
which fits a frailty model to the random effects. The standard methodology
suggested that an additive genetic model best described the data. The
most parsimonious model when using the frailty method included additive
genetic and common environmental effects (ACE). The difference between
the two models was caused by the different ascertainment of the siblings. The
frailty model estimated the heritability of age at menarche to be 0.57 (Chapter 4).
vi
In Chapter 5, a sample of 2,685 pseudo-independent sib-pairs is used in a genome-
wide linkage scan for QTL underlying variation in age-at-menarche. The sample
comprises of the adolescent sample discussed in chapter 4, and three adult
cohorts. The proportion of censoring in the sample is 1.20% so a standard QTL
mapping method is used. Two QTL of suggestive significance are identified on
chromosomes 11p and 3p. The candidate genes WT1 and FSHB are located
within the linkage peak on 11p. After the removal of bivariate outliers a locus
on chromosome 12q was identified. No significant QTL were detected which
suggests age-at-menarche is influenced by multiple genes of small effect. The
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1.1 Identifying factors underlying human variation
With over 6.5 billion people on the planet no two individuals are phenotypically
identical. Even between identical twins most traits, from height to personality
to disease susceptibility, show variation. The amount of variation between
individuals differs from one trait to the next. What are the causes underlying
this variation? The simplest answer is chance; any variation between two
individuals is just random variation around the trait mean. This, however, does
not explain the observation that, on average, two closely related individuals are
more phenotypically similar than two unrelated individuals. Are there factors
associated with relatedness that influence trait variation? Related individuals
share both environmental and genetic factors to a greater extent than unrelated
individuals. For a trait where variation is explained largely by genetic and/or
common environmental factors, two related individuals will have, on average, a
greater similarity than two unrelated individuals. Identical (monozygotic) twins,
who share all genes in common, and non-identical (dizygotic) twins, who share
on average 50% of their genes in common, can be used to partition the trait
variation into genetic, common environment, and error (random) components
(see Chapter 4).
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For many traits, for example height, body mass index (BMI) or IQ, a large
proportion of the variation between individuals is explained by genetic factors.
Much work has been carried out to identify the genetic loci which underpin this
variation. It is hoped that insights into the underlying biology of a trait will be
gained by identifying genetic loci underlying trait variation. Identifying genetic
loci which cause variation in human disease susceptibility has a large potential to
improve our understanding of the disease, our treatment of the disease and our
ability to identify those individuals at high risk. The ease with which one can
map such genetic loci depends largely on the genetics underlying each trait. In
genetical terms, traits can be broadly characterised into two groups, Mendelian
traits and complex traits.
1.2 Mendelian traits
Mendelian traits are named after Austrian monk Gregor Johann Mendel (1822-
1884) who is considered the ‘Father of Genetics’ for his groundbreaking research
into the principles of heredity. They represent the simplest case of genetic
causation and occur when phenotypic variation within a family is explained by
the genotype at a single locus. The genotype at the locus is said to be both
necessary and sufficient for the change in phenotype. Because Mendelian traits
are fully influenced by the genotype at a single locus, they are dichotomous
traits (i.e. either present or absent).
Mendelian traits are easily recognised because they show clear inheritance
patterns in families. If the Mendelian trait is manifest to an equal extent in
individuals with one or two copies of the trait allele, then that characteristic is
said to be dominant. Typically, dominant traits have a distinctive pattern of
transmission within families. An affected individual classically has at least one
2
affected parent (if the trait is sex linked then this is not necessarily the case). If
the affected parent is heterozygous at the disease locus (i.e. the affected parent
has both a wild type allele and a disease causing allele at the disease locus) and
the other parent is unaffected, which is typically the case for rare conditions,
then approximately half the offspring will display the trait. A classic example of
an autosomal dominant trait is Huntington’s disease [OMIM 143100].
If the Mendelian phenotype is present to a greater extent in homozygotes
than heterozygotes then the trait is said to be semi-dominant or codominant.
Waardenburg syndrome [OMIM 193500] is a semi-dominant trait which occurs
in humans. Heterozygotes manifest the classic Waardenburg symptoms (Type
1) and homozygotes display a more severe form of the syndrome (Type 3) (Hoth
et al., 1993). If both affected parents are heterozygotes at the disease locus,
then half of the offspring will be heterozygotes and have Waardenburg syndrome
type 1, a quarter of the offspring will be homozygous for the disease allele and
have Waardenburg syndrome type 3, and a quarter will be unaffected. A special
case of codominant inheritance is additive or dose-dependent inheritance, which
occurs when the phenotype displayed by the heterozygotes is halfway between
that of the two homozygotes.
If the Mendelian characteristic is only expressed in individuals who carry two
copies of the trait allele (i.e. are homozygous for the trait allele) then the
phenotype is said to be recessive. Parents of affected individuals do not display
the recessive trait because they are typically heterozygous at the trait locus. In
the case of consanguineous marriages the chance of both parents carrying the
same recessive disease allele is increased. Thus, the incidence of recessive traits
is increased in cases of parental consanguinity. Cystic fibrosis [OMIM 219700] is
a classic example of a recessive trait.
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There are a number of complications that change the basic Mendelian pedigree
patterns (Scriver and Waters, 1999; Weatherall, 2001; Badano and Katsanis,
2002). Occasionally, while the trait is still caused by the genotype at a single
locus, the phenotype may display incomplete penetrance. Incomplete penetrance
occurs when the probability of the phenotype given the genotype is less than 1
(i.e all carriers of the disease allele will not necessarily display the phenotype).
The penetrance of a particular phenotype can change with age, because while
the genotype is fixed at conception, the corresponding phenotype may not
present itself until late into adulthood. Huntington’s disease [OMIM 143100],
a neurodegenerative disease, is a good example of a Mendelian disease with a
variable age at onset.
1.2.1 Mapping Mendelian traits
The mapping of genetic loci requires polymorphic genetic markers which allow
one to follow chromosomal segments through a pedigree. The identification
of restriction-fragment length polymorphism (RLFP) markers (Botstein
et al., 1980) and highly polymorphic microsatellite (short tandem DNA repeat)
loci (Tautz, 1989; Weber and May, 1989) during the 1980s led to increased
interest in the identification of loci underlying Mendelian traits. Microsatellite
markers are highly polymorphic, so a randomly selected individual is likely to be
a heterozygote, and therefore informative for mapping genetic loci. Furthermore,
both microsatellites and RFLPs are found frequently throughout the entire
genome (Strachan and Read, 2003). Prior to the discovery of these markers,
most disease mapping studies followed a functional cloning paradigm. Candidate
genes were chosen based upon knowledge of their gene-product and their role in
a disease pathway. Indeed, this was the method used to map phenylketonuria
(PKU) [OMIM 261600] to the hepatic enzyme phenylalanine hydroxylase
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(PAH) gene, one of the first Mendelian disease to be successfully mapped to
a genetic locus (Woo et al., 1983). However, the advent of highly-polymorphic
genome-wide markers allowed a migration away from the hypothesis driven
functional cloning paradigm and towards hypothesis-free positional cloning.
Positional cloning, initially termed ‘reverse genetics’, requires no knowledge of
the biology underlying the trait (Collins, 1992; Collins, 1995). Loci are identified
solely on the basis of their map position. In the early years, cytogenetics was
used to identify individuals with translocations which resulted in Mendelian
disease. Positional cloning would then be carried out along the relevant
chromosomes to identify the causal locus. One of the first Mendelian disorders
to be mapped in this way was Duchenne muscular dystrophy [OMIM 310200]
(Monaco et al., 1986). As the cost of genotyping marker loci decreased, it became
possible for genome-wide scans to be carried out to detect linkage between a
marker locus and a disease locus. As this technology became more widely
available, the need for cytogenetic studies to identifying candidate chromosomes
decreased. The first Mendelian disease to be fully mapped using only positional
cloning was cystic fibrosis (Tsui et al., 1985).
If one is attempting to map a Mendelian trait, the method of choice is parametric
(model based) linkage analysis (Ott, 1992; Terwilliger and Ott, 1994). Linkage
occurs when two genetic loci are not segregating independently. Linkage analysis
attempts to detect co-segregation between a marker locus and a particular trait
of interest. As the mode of inheritance (dominant, codominant, recessive) is
clearly observed in the pedigrees, these models can be applied in the analysis
to increase the power to detect linkage through the use of parametric analysis
methods. Furthermore, if, through the analysis of the pedigrees, it is suspected
that a locus with incomplete penetrance is underlying the variation in the trait,
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this can also be modelled. The age-specific penetrance of the disease can also be
included in the model to account for unaffected individuals who are not yet at
risk (Chapter 2). Throughout this thesis, parametric linkage analysis is defined
as a method for which a genetic model (for example, a particular set of disease
allele frequencies q and penetrances f0, f1, f2) is applied to the linkage analysis
by the user, typically following the visual inspection of the pedigrees. Therefore,
parametric methods are defined as those for which assumptions must made
regarding the genetic effect of the susceptibility locus.
To date, almost 2000 Mendelian characteristics have been mapped
to genetic loci, and almost 10,000 have been mapped to a
particular chromosome (Online Mendelian Inheritance in Man [OMIM]
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM, 25th October
2006). The ease with which a genetic locus can be mapped for a given trait,
is directly related to the genotypic relative risk at that locus for the given
phenotype. Therefore, due to their large phenotypic effect, Mendelian traits
are the easiest to map. However, the majority of human phenotypic variation
does not follow simple Mendelian inheritance patterns, and these phenotypes are
referred to as complex traits.
1.3 Complex traits
The exact boundary between Mendelian and complex traits is vague; here
a complex trait is defined as a trait which, at the population level, is not
explained by the genotype at a single locus. These traits do not follow the simple
Mendelian inheritance patterns discussed earlier. Some complex diseases, such as
polycystic kidney disease [OMIM 173900] (Pei, 2003) or early-onset Alzheimer’s
disease [OMIM 104300] (Scott et al., 2000), have locus heterogeneity (multiple
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disease loci segregating in a population). Any one of these loci is sufficient for
the occurrence of the disease phenotype, but for rare conditions it is likely that
only one such polymorphism will be segregating within a single family. If this is
the case, then a disease which is complex at the population level, can appear to
be Mendelian at the family level. However, for common complex diseases with
locus heterogeneity, there can be multiple disease alleles segregating within a
family.
Only traits that, at the level of the individual at least, are explained by the
genotype at a single locus have been discussed so far. However, a complex trait
within one individual (and the population) can also be influenced by multiple
genetic factors. If a complex trait is caused by a small number of moderate
effect loci, that trait is said to be oligogenic. If a multitude of small effect genes
underlie variation in the phenotype, that trait is referred to as polygenic. The
presence of any one risk allele is insufficient for the presence of the phenotype
in both oligogenic and polygenic traits. Retinitis pigmentosa [OMIM 268000] is
an example of an oligogenic disorder that occurs in humans, the presence of the
disease requires a mutant heterozygote at a locus in both the RDS and ROM1
genes (Kajiwara et al., 1994). Such interaction between genetic loci is referred
to as epistasis (the joint effects of the loci are greater than the sum of their
independent actions). Not all oligogenic or polygenic traits display epistasis, the
effects of different loci can also act additively.
Polygenic traits can be classified as either binary traits or quantitative traits.
Binary traits indicate the presence or absence of a particular trait of interest
(for example dwarfism or high blood pressure), whereas quantitative traits are
measured on a continuous scale (for example height or diastolic blood pressure).
Polygenic binary traits can also be modelled as quantitative traits if one assumes
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that the phenotypic ‘liability’ is an unobserved continuous trait. It is assumed
that the trait is present after some critical threshold of susceptibility has been
surpassed (Falconer and Mackay, 1996).
Complex traits are often not only influenced by genetic effects. Environmental
influences also underlie variation in most complex traits. Furthermore,
interactions can occur between environment influences and alleles at particular
loci. For example, a genetic predisposition may only be evident in the presence
of certain environmental cues. For some genetic traits, individuals without any
predisposing risk alleles can display the same phenotype, and these individuals
are said to be phenocopies. Phenocopies are caused either by environmental
effects or random chance.
The genetic architecture of most complex diseases is still largely unknown. For
most traits only a few causal polymorphisms have been identified, and these are
typically of large effect (e.g. the BRCA polymorphisms underlying breast cancer
susceptibility in familial forms of breast cancer (Easton, 1999)). However, it would
be wrong to conclude that complex traits are influenced by only a few genes of
large effect. It has been suggested that currently identified susceptibility loci
represent the ‘low-hanging fruit’ (i.e. the identified susceptibility variants have
a more complete penetrance, larger effect size, and simpler allelic architecture
then the majority of loci underlying complex traits) (Pritchard and Cox, 2002).
It is likely that a multitude of small effect polymorphism influence variation in
complex traits, but these are yet to be mapped.
1.3.1 Mapping complex traits
The mapping of complex traits is much more difficult than the mapping of
Mendelian traits. Locus heterogeneity, incomplete penetrance, oligogenic or
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polygenic loci, epistasis, gene by environment interactions and phenocopies can all
hinder the search for linked genetic loci (Lander and Schork, 1994; Risch, 2000).
In comparison to Mendelian traits, a much greater number of individuals is
required to map loci underlying variation in complex phenotypes. The number
of individuals required to map a locus is directly related to the phenotypic effect
size of the locus, the smaller the effect size the greater the number of individuals
required to map the locus.
Several strategies have been suggested to remove some of the complexities when
mapping quantitative trait loci (QTL). Many researchers have suggested that
choosing narrowly defined subsets of complex disease will result in the selection
of more homogeneous individuals (i.e. increased genotypic homogeneity as a
result of less phenotypic heterogeneity) (Rice et al., 2001). It is hoped that, by
selecting these narrowly defined subsets of complex disease, a group of families
can be identified that are segregating a rare polymorphism of large effect (see
Chapter 2). These polymorphisms will present with near-Mendelian inheritance
patterns in carefully selected pedigrees. This method was put to good use in the
mapping of two breast cancer genes, BRCA1 (Hall et al., 1990; Miki et al., 1994)
and BRCA2 (Wooster et al., 1994; Wooster et al., 1995).
Others have suggested that rather than use end-phenotypes (disease status)
in linkage analyses, efforts should be made to carry out linkage analysis on
intermediate phenotypes (endophenotypes). For example, rather than testing
for linkage to myocardial infarction, one may want to test for linkage to blood
pressure or cholesterol level. The rationale here is that the endophenotypes are
closer to the gene action than the disease end-point. Using brain oscillations
in the beta frequency range (1328 Hz), Edenberg et al. (2004) identified the
GABRA2 gene as a candidate gene for alcohol susceptibility. They conclude
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that GABRA2 influences susceptibility to alcohol dependence by modulating the
level of neuronal excitation.
In addition to the careful selection of individuals and phenotypes for mapping
complex traits, special statistical methods must be used to detect linkage to
complex traits. The parametric linkage method described earlier is no longer
the method of choice because the mode of inheritance of the complex trait is
usually unknown. Under the correct mode of inheritance, parametric methods
have more power than non-parametric methods (Goldgar, 2001). However,
non-parametric methods have relatively high power with all modes of inheritance
(Clerget-Darpoux et al., 1986; Kruglyak et al., 1996). Most attempts to map
complex traits are therefore carried out using non-parametric methods such as
affected sib-pair methods, regression methods or variance components methods.
Throughout this thesis, non-parametric methods are defined as methods for
which no assumptions regarding the genetic effect of the risk alleles at the
susceptibility locus are made. Rather than these parameters being fixed by the
investigator they are explicit or maximized within the model.
Due to the complexities described above, and despite the large number of
studies searching for genetic loci underlying variation in complex traits, few
traits have been unequivocally mapped to genetic loci (Glazier et al., 2002).
Positional cloning linkage analysis was used to identify a susceptibility gene
for Crohn’s disease (Hugot et al., 2001; Ogura et al., 2001). Following linkage
and association studies, a positional candidate gene approach was used to
identify frameshift and missense mutations within the NOD2/CARD15 gene
that were associated with Crohn’s disease. Other complex traits for which
susceptibility genes have been identified include Alzheimer’s disease (ApoE)
(Corder et al., 1993), type 1 diabetes (INS) (Bell et al., 1984), type 2 diabetes
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(PPARγ, CAPN10) (Altshuler et al., 2000; Horikawa et al., 2000), asthma
(ADAM33) (van Eerdewegh et al., 2002) and macular degeneration (CFH)
(Haines et al., 2005; Klein et al., 2005).
With many diseases, susceptibility is not constant throughout an individual’s
lifetime. For example, Huntington’s disease susceptibility is directly related to
the number of trinucleotide repeats at the Huntington’s disease locus, the more
repeats the earlier the onset of the disease. Further insights into the genetics
underlying a trait can be gained by using the age at onset of a trait as the
phenotypic data in a QTL mapping experiment. For example, it is perhaps more
pertinent to use the age at onset of high blood pressure when searching for QTL
than to use presence or absence of high blood pressure. The rationale here is
that the genetics underlying early onset high blood pressure are different to those
underlying late onset high blood pressure. Age at onset traits have a number of
special features which differentiate them from standard traits.
1.4 Age at onset traits
Age at onset data are an example of survival data, which is the term used to
describe data giving the length of time from a start point until the occurrence of
a particular event (or end point). In genetic studies, the start time (t0) typically
represents the time at which an individual is recruited into a study. If the event
of interest is death then the data are truly survival times. However, the event
of interest can be any event which can be clearly defined and readily timed.
For example, the event of interest could be pregnancy, pacemaker failure, the
re-occurrence of pain following anaesthesia or the absence of disease symptoms
following a given treatment. The survival study design typically involves
recruiting a cohort of individuals and repeatedly following-up these individuals
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Figure 1.4.1: An example of 7 individuals (A to G) recruited to a survival study.
EV = occurrence of the event of interest, L = lost to follow-up. Individuals
A, D and F are uncensored and individuals B, C, E and G are censored.
Individuals C and G are lost to follow-up and individuals B and E are censored
because the event of interest had not occurred before the end of the study
until a previously defined point in time that marks the end of the study. At each
interview the presence or absence of the event of interest is recorded. Once the
event of interest has occurred for a given individual, that individual is no longer
followed up. Figure 1.4.1 gives a typical example of 7 individuals from a survival
study.
Survival data have several special features which separate them from standard
quantitative trait data. Survival traits do not typically follow a normal or
symmetrical distribution, and are frequently seen to be right skewed (i.e.
positively skewed). In addition, the survival time of an individual may be only
partially observed (i.e. the true time to event is unknown, it is only known that
the event had not occurred at the time of last interview). The survival times of
these individuals are said to be censored. In Figure 1.4.1, individuals B, C, E
and G are censored. There are many reasons why an individual may be censored.
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Firstly, individuals may be lost to follow-up, which indicates that they have left
the study before the event of interest has occurred and before the end of the
study period (individuals C and G in Figure 1.4.1 are lost to follow-up). For
these individuals, it is only known that the event of interest had not occurred
before they were lost to follow-up. Loss to follow-up can occur for many reasons
including death (assuming the event of interest is not death) or the individual no
longer wishing to participate in the study. Secondly, the study may end before a
particular individual has experienced the event of interest, which is the case for
individuals B and E in Figure 1.4.1. Due to the non-symmetrical distribution of
the data and the presence of censored observations, special statistical tools are
required to analyse survival data and map QTL for survival traits.
1.4.1 Mapping age at onset traits
If, due to a long period of follow-up and little loss to follow-up, the proportion
of censoring in a sample is small then standard QTL mapping methodology can
be used to analyse survival data. A transformation can be used to ‘normalise’
the distribution of survival times, which can remove the error introduced by
using standard methodology to analyse survival traits. Alternatively, using
the allele specific age at onset distribution of the uncensored individuals, the
survival time of an individual censored at time x can be simulated. This method
was implemented by Daw et al. (1999) to successfully map two previously
known Alzheimer’s disease susceptibility loci (PS1 and PS2) in a sample of
1,150 German individuals. This method is far from ideal as it assumes that
all individuals will eventually experience the event of interest and this is not
the case for many diseases, including Alzheimer’s disease. When a reasonable
proportion of individuals are censored, survival analysis methodology must be
employed to analyse the data without introducing error. Several special ‘survival
analysis’ methods have been developed to account for both the non-normal
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distribution and the censored nature of the data when mapping QTL for age at
onset traits. When compared to standard methods, survival analysis methods
not only remove the bias introduced by the censored observations but also
increase the power to detect linkage (Epstein et al., 2003; Moreno et al., 2005).
Many of the fundamental methods for mapping QTL for survival traits come
from work carried out using experimental species and inbred lines. The mapping
of QTL in these species is simpler than in outbred populations because the
parental lines are usually fully inbred, and thus a maximum of two alleles are
segregating at a given locus within the population. Several methods have been
proposed for mapping QTL in inbred lines including those of Symons et al.
(2002), Diao et al. (2004) and Diao and Lin (2005).
The mapping of QTL for survival traits in outbred populations is further
complicated by the fact that survival times of individuals within a family are
no longer independent. To model the correlation in survival times between
individuals within a family, a correlated random effect (a frailty) must be used.
Li (2002) proposed an additive gamma frailty model for linkage of age at onset
traits. The gamma frailty model fits a gamma distributed random effect to the
additive effect of the QTL in each founder in the population. The method is
non-parametric and is therefore suitable for mapping QTL underlying complex
age at onset traits. However, additional frailties must be calculated if one
wishes to apply the method to extended families and this renders the maximum
likelihood method intractable.
Subsequently, other methods have been suggested which follow the variance
components framework typically used to map non-survival traits in outbred
populations (Epstein et al., 2003; Pankratz et al., 2005; Diao and Lin, 2006).
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As with standard complex trait analysis, parametric methods are not ideal
because the distribution of the data is usually unknown. The methods of Diao
and Lin (2005), Pankratz et al. (2005) and Diao and Lin (2006) are based upon
the popular Cox semi-parametric model (Cox, 1972), and are therefore more
suitable for analysing complex trait survival data. These methods, whilst more
computationally intensive than the corresponding non-survival methods, can be
used to map QTL and estimate variance components underlying age at onset or
survival traits in outbred populations.
To date, most age at onset traits used in genetic linkage studies have been
retrospective studies and have therefore not included censored data. Standard
QTL mapping methodology is typically applied to these datasets. Perhaps due
to the complexities involved in the analysis, few survival traits have been used in
genetic mapping studies. Alcais et al. (2001) identified a locus on chromosome 6q
underlying variation in wheezing age at onset in a sample of German Asthmatics.
1.5 Thesis Overview
This thesis aims to use age at onset information to identify loci underlying
quantitative and disease traits. This is approached both directly through the use
of age at onset data in QTL mapping experiments and indirectly by modelling
the age-dependent penetrances in genome-wide scans for linkage. Methods
which account correctly for age at onset data and age-dependent penetrances
are compared and contrasted to standard methods. Where appropriate new
methods are suggested for the analysis of survival data.
In Chapter 2, parametric linkage analysis is carried out on four families with
major depression and unexplained swelling (a novel comorbidity). The age-
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related disease susceptibility is modelled in the unaffected individuals to account
for those individuals yet to enter the high risk age group. The parametric linkage
analysis method (which accounts for the age related disease susceptibility) is
compared and contrasted to a non-parametric linkage analysis method (which
does not account for the age related disease susceptibility).
A novel method for linkage analysis of continuous age at onset data from
inbred lines is proposed in Chapter 3. Because the method is based upon
linear regression methodology, it can be readily implemented in many standard
statistical packages. The new method is compared in terms of efficiency and
power to those currently available.
In chapter 4, a biometric twin analysis is carried out on age at menarche data
collected from a sample of Australian adolescent twins. This is an important first
step when aiming to understand the factors underlying variation in a trait, and
one which should be completed before attempting to map genetic loci. Variance
components are estimated using both a survival analysis method and standard
method. The results of the two methods are compared and discussed.
Age at menarche data was also available for three large Australian adult samples.
There is no censoring in the adult sample and therefore the overall proportion of
censoring in the combined adult and adolescent sample is small. In chapter 5, a
standard variance components linkage analysis is used to identify loci underlying
variation in age at menarche. A general discussion of the thesis and future
direction of the field is provided in chapter 6.
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Chapter 2
Genome-wide linkage analysis of




Recurrent major depressive disorder (MDD [OMIM 608516]) or unipolar
depression, is a common psychiatric disorder predicted to rank second only to
ischaemic heart disease as a source of disability world-wide by the year 2020
(Murray and Lopez, 1996). The US National Comorbidity Survey (NCS) reported
a lifetime prevalence for major depressive episode of 21.3% in women and 12.7%
in men (Kessler et al., 1994). In a replication of the NCS, a measure of illness
severity was included and the twelve month prevalence of MDD was estimated at
6.7%. Of these, 30% were rated as serious causing substantial disability in work
and daily living or serious suicide intent (Kessler et al., 2003; Kessler et al., 2005).
Genetic factors have a substantial role in unipolar depression. Relatives of MDD
sufferers are more likely than controls to develop illness and have a greater
than twofold increase in relative risk (Sullivan et al., 2000). Young offspring
who have both a parent and a grandparent with depression are especially at
17
risk (Weissman et al., 2005) and twin studies have consistently shown that
genetic factors account for 40-70% of the risk for developing unipolar depression
(Sullivan et al., 2000). The risk of depression developing among family members
is increased with early age at onset (under the age of 30) (Mendlewicz and
Baron, 1981; Weissman et al., 1984; Wickramaratne et al., 2000; Kendler
et al., 2005) and a twin study of depressive symptoms in adolescence produced
a heritability estimate as high as 0.79 (Thapar and McGuffin, 1994). Familial
effects are also increased when depression is recurrent (Bland et al., 1986; Kupfer
et al., 1989).
The mode of inheritance of MDD is unknown and a variety of genetic mechanisms
are possible. No single genetic model is likely to explain the familial aggregation
of all subtypes of the MDD phenotype. A quantitative meta-analysis of 5
twin studies concluded that familial aggregation could be explained by additive
genetic effects (37%), and individual specific environmental effects (Sullivan
et al., 2000). Several segregation analyses have been carried out on families
selected through MDD probands (Cox et al., 1989; Marazita et al., 1997; Maher
et al., 2002). The results of these segregation analyses have been inconsistent
and inconclusive, perhaps because the results depend heavily on the definition
of disease and population prevalence parameters, making them difficult to
replicate between studies. A transmitted non-Mendelian recessive major effect
locus with significant residual parental effect was the best model for a narrow
definition of MDD. In the same study, a Mendelian co-dominant major effect
locus with significant parental and spousal effect was the best fitting model
under a more broad definition of the disorder (Marazita et al., 1997). A recent
study of pedigrees ascertained through a proband with recurrent early onset
unipolar depression has reported genetic segregation consistent with a Mendelian
dominant model. The presence within some families of a single major locus for
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early onset depression seems likely (Maher et al., 2002).
Genetic linkage analyses have been inconsistent, and many results have failed
to be replicated across studies. The multifactorial aetiology of the disease and
difficulties defining subsets of the disease are believed to be the main reason
for the inconsistencies. Furthermore, in linkage studies, MDD has often been
included with the bipolar affective disorders and used as a very broad definition
of a mood or affective disorder (Venken et al., 2005). Of the genome-wide linkage
scans that selected probands based on an MDD phenotype, four have found
regions of significant linkage. Abkevich et al (2003) included bipolar family
members as affected and found linkage to 12q in males only. Holmans et al.
(2004) found linkage to 15q and Camp et al. (2005) reported linkage on 3p and
18q. Nurnberger et al. (2001) included alcoholism in the phenotype definition
and found linkage to 1p. Suggestive evidence of linkage to chromosome 1p was
found following a genome scan by McGuffin et al. (2005) in a region which
included the MTHFR gene previously associated with depressive symptoms.
The candidate gene CREB1, on chromosome 2q, was shown to be linked with
early onset MDD (Zubenko et al., 2002) and again by the same group in a follow-
up genome scan (Zubenko et al., 2003). No linkages to MDD have yet been
replicated. Many other groups have looked for association or linkage of MDD to
candidate loci but have failed to produce significant results (Balciuniene et al.,
1998; Serretti et al., 2000; Zill et al., 2002). It has been suggested that these
inconsistent results can be reduced by selecting probands with a narrow definition
of the disease, a similar severity, age at onset, gender and symptom profile (Rice
et al., 2001; Camp and Cannon-Albright, 2005). The aim is to reduce the impact
of heterogeneity and environmental influences by selecting a homogeneous sub-
sample of MDD.
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Unexplained swelling symptoms (also known as idiopathic oedema or the
fluid retention syndrome) are strongly associated with affective symptoms,
including depression. Patients with idiopathic oedema exhibited significantly
more evidence of affective disturbance, including major depression, than a group
of female hospital outpatients (Pelosi et al., 1986). The clinical phenotype
comprises swelling symptoms involving the face, hands, breasts, abdomen and
feet. The swelling worsens from morning to evening and is associated with a
weight gain from 1-4 Kg. Objective evidence of pitting oedema is usually absent.
Symptoms frequently present in post-pubertal females, and occasionally in
pre-pubertal girls. Cases of swelling symptoms have occasionally been reported
in men (Thorn, 1968; Edwards and Baylis, 1976; Streeten, 1978). Medical and
physiological investigations exclude cardiac, hepatic, hypoproteinaemic and
obstructive causes of oedema. Complement levels are normal, and features
do not include urticaria, abdominal pain attacks or episodes of upper airway
obstruction, thus distinguishing the condition from angioedema (Dunnigan
and Pelosi, 1993). Unexplained swelling symptoms appear to be a component
of a common syndrome characterised by affective symptoms (depression,
irritability, anxiety, poor concentration, food cravings and sleep disturbance),
somatic symptoms (fatigue, pain at several sites, headaches and visual blurring)
and autonomic symptoms (flushing, urinary frequency, sweating, faintness,
constipation and diarrhoea). Weight gain, obesity and a family history of
swelling and diabetes mellitus are also associated with swelling symptoms.
These affective, somatic and autonomic symptoms are shared by overlapping
symptom clusters including fibromyalgia, chronic fatigue syndrome, irritable
bowel syndrome, and pre menstrual syndrome. These conditions represent a
common group of poorly understood syndromes that constitute a significant part
of primary care and general hospital case load (Kroenke and Mangelsdorff, 1989).
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A recent study examined the prevalence of unexplained swelling symptoms in the
community (Dunnigan et al., 2004). The study comprised 198 women attending
a fracture clinic (median age 45, range 17 to 82 years), and 201 women attending
their general practitioner (median age 40, range 16 to 77 years). The self reported
prevalence of mild to severe swelling symptoms in the previous month was 33%
and 28%, respectively. A logistic regression model of risk factors associated
with swelling symptoms was applied to a dataset derived from a fracture clinic
sample (n=198) and women attending a menopause clinic (n=201). Severe
affective symptoms (Relative risk (RR) 43, 95% Confidence Interval (CI) 16-112,
P <0.001) and moderate affective symptoms (RR 7.8, 95% CI 4-15, P <0.001),
a family history of swelling symptoms (RR 4.5, 95% CI 2.3-8.8, P <0.001) and a
body mass index (BMI) > 25kg/m2 (RR 4.8, 95% CI 2.5-8.9, P <0.001) were all
significantly associated with mild to severe swelling symptoms assessed by visual
analogue scales. In summary, affective symptom severity provides the principal
independent contribution to swelling symptom risk. BMI > 25 and a family
history of swelling symptoms provide smaller independent contributions. The
nature of the mechanisms underlying these associations remains uncertain. The
aim of this present study is to identify loci underlying susceptibility to MDD
using a narrowly defined subset of the disease. A genome-wide scan for linkage
is performed on four unrelated families whose affected members demonstrate




Four families with multiple cases of depression and unexplained swelling are
described in Figure 2.2.1. The study was approved by the appropriate Multicentre
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Research Ethics Committee and all participants gave full written informed
consent. Families were ascertained by Dunnigan et al. (2004) in the course of
a large study of the prevalence of unexplained swelling symptoms in hospital and
general practice clinics. A branch of family 224 was first described by Dunnigan
and Pelosi (1993). An operational clinical diagnosis of unexplained swelling was
based on a description by the patient of intermittent swelling or bloating at
two or more sites (face, abdomen, breasts, hands and feet) over at least six
months, and usually for several years. Clinical examination with appropriate
investigations, excluded hereditary angioedema, fibromyalgia and cardiac, renal,
obstructive and hypoproteinemic causes of swelling. All family members were
examined in the clinic or at home and a diagnosis of unexplained swelling made
using the same operational criteria. Home interviews were also carried by a
trained psychiatrist and a psychiatric research nurse using The Schedule for
Affective Disorders and Schizophrenia. Diagnoses according to DSM-IV criteria
(American Psychiatric Association, 1994) were reached by consensus between the
interviewing psychiatrist and two other psychiatrists. From a total of 47 affected
individuals, 28 had both MDD and unexplained swelling, while 8 had MDD only
and 11 had unexplained swelling only.
2.2.2 Genotyping and error checking
Venous blood samples were obtained and genomic DNA was extracted from
the peripheral lymphocytes using a standard salting out procedure by Genovar
Biosciences (Miller et al., 1988). PCRs were performed in a 12µl reaction volume
containing 2.5pmol of each primer, 1 x Sigma PCR buffer, 0.2mM dNTPs, 0.25
units of Sigma Taq and 20ng of genomic DNA. The ABI Prism Linkage Mapping
Set-MD10 (version 2) primers were used (average heterozygosity 79%). One
of three dyes (FAM, HEX and NED) were used to label 312 microsatellites,





































































The average marker density was 12cM. An MJ Research PTC-225 DNA Engine
Tetrad (MJ Research) was used to amplify DNA fragments with 35 cycles of 20
seconds at 94°C, 30 seconds at 55°C, and 1 minute at 72°C. This was preceded by
an initial denaturation step of two minutes at 94°C and ended with an extension
step of 30 minutes at 72°C. PCR products were pooled for each panel and run
in an ABI 377 automated DNA sequencer or ABI 3730 DNA Analyser with
either 400HD rox or GS500 liz size standard. Allele sizes were determined using
either GENOTYPER (3.6) or GENEMAPPER (3.0) analysis software (Applied
Biosystems), then subsequently checked for quality manually. All genotyping
was carried out by Alan Maclean at the Molecular Medicine Centre, University
of Edinburgh, UK.
The genotypes were checked for inheritance errors using PEDCHECK (O’Connell
and Weeks, 1998). Marker genotypes producing Mendelian segregation errors
were removed from the study by re-classifying the marker genotypes of the
relevant family members as unknown. The ABI marker map was used because
this was calculated using a greater marker coverage than the present scan, and
therefore provides better estimation of intermarker distance. A flips analysis was
implemented through CRIMAP (Lander and Green, 1987) to check the given
marker order was the most likely. A difference of -3 between the log10likelihoods
of the original and hypothesized marker order was deemed significant enough
evidence to reject the original marker order and remove the marker from further
analyses. This level of significance equates to the hypothesized marker order
being at least 1000 times more likely than the original marker order.
2.2.3 Parametric linkage analysis
Single-point parametric linkage analysis was carried out across all autosomes
and the X chromosome using LINKAGE (Lathrop et al., 1984). Parametric
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linkage analysis has proven to be a powerful technique for mapping Mendelian
diseases with well defined modes of inheritance (Tsui et al., 1985). As a mode
of inheritance must be specified for parametric linkage analysis its application
in the analysis of complex traits is not straightforward. Greenberg et al. (1998)
have shown that with a limited number of simple models, both dominant and
recessive, parametric analysis can be successfully applied to complex disease.
For single-point analysis, model misspecification can result in an upward bias
in the estimation of the recombination fraction, while the strength of the
reported LOD score remains unbiased provided dominance is correctly specified
(Clerget-Darpoux et al., 1986; Risch and Giuffra, 1992).
Two definitions of disease were used throughout the study to better model the
comorbidity of the phenotype. The narrow definition defined individuals as
affected if they were diagnosed with MDD, regardless of unexplained swelling
affection status. The broad definition extended the narrow definition to include
those individuals with only unexplained swelling (i.e. individuals with MDD
and/or unexplained swelling are given as affected). An autosomal dominant and
an autosomal recessive model were fitted under each disease definition, totalling
four models for parametric linkage analysis. For the dominant and recessive
models, disease allele frequencies of 0.012 and 0.300 were assumed, respectively.
These are similar to those suggested from simulation (Pal et al., 2001). Allele
frequencies for all markers were set equal, i.e., the frequency for any given allele
was set to 1/n, where n is the total number of observed alleles. For each model,
unaffected individuals were classified into one of five groups (<20yrs, <30yrs,
<40yrs, ≥40yrs, and ‘married in’) to allow the age-dependent penetrance of
MDD and US to be modelled (see chapter 1). The penetrance parameters used in
the parametric linkage analysis are shown in Table 2.2.1. The model parameters
were provided by Professor Douglas Blackwood of the University of Edinburgh
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and are similar to those parameters used in the analysis of other psychiatric traits.
A series of marker-specific LOD scores were produced across all 23 chromosomes.
A LOD score greater than or equal to 3.3 was accepted as genome-wide
significance, which corresponds to a genome-wide false-positive rate of 0.05 or an
asymptotic P-value of 0.000049, thus accounting for the multiple testing taking
place in genome-wide scans for linkage (Lander and Kruglyak, 1995).
2.2.4 Further genotyping
A further 59 microsatellite markers from the ABI Prism Linkage Mapping set
MD10 (version 2) were genotyped. The additional genotyping was carried out
in regions of low marker information content. In total, 371 markers were spaced
at an average density of approximately 10cM. The data were again checked for
genotyping errors using PEDCHECK and CRIMAP (O’Connell and Weeks, 1998;
Lander and Green, 1987). All identified errors were removed from the analysis
and single-point parametric linkage analysis was repeated using the same models
as in the initial analysis. Marker allele frequencies were estimated from all family
members using Merlin (Abecasis et al 2002).
2.2.5 Affecteds only parametric linkage analysis
The modelling of complex diseases in parametric linkage analysis is difficult
because penetrance, disease allele frequencies, population prevalence and
phenocopy rates are uncertain. It is especially difficult to provide age-specific
disease penetrances for unaffected individuals when the disease onset and
susceptibility has not been well characterised. An affecteds only analysis, which
models the disease only in affected individuals, was implemented using the same
disease parameters as in the full analysis. Unaffected individuals had their disease












































































































































































































































































































































































































































































































































































































































analysis to the ‘full’ analysis, the effect of including the unaffected individuals in
the model and modelling the age-specific disease penetrances in these individuals
can be seen. An alternative approach would be to use a single set of penetrance
parameters for the unaffected individuals (i.e. do not model the age-dependent
penetrances in the unaffected individuals). This method has the advantage
that the unaffected individuals remain in the analysis. The disadvantage of
this method is that one still needs to derive a set of penetrance parameters for
unaffected individuals, and these are difficult to obtain.
2.2.6 Non-parametric variance components analyses
A genome-wide variance component linkage analysis was carried out using the
two step approach of George et al. (2000), which has been shown to detect
QTL for complex psychiatric disorders (Visscher et al., 1999). This method
does not specify a genetic model for the trait, but identifies regions that explain
a significant proportion of the phenotypic variation. The two definitions of
disease used during the parametric analysis were again applied. Phenotypes were
coded as a binary trait, with 1 for affected and 0 for unaffected. Identity-by-
descent (IBD) coefficients between all genotyped individuals were calculated by
the Markov Chain Monte Carlo method using LOKI (Heath, 1997). A simple
linear model was assumed with regard to the MDD phenotype. Restricted
maximum likelihood analysis (Lynch and Walsh, 1998) was performed using
ASREML (Gilmour et al., 2002). REML estimates variance components whilst
taking account of the number of degrees of freedom used by fitting fixed effects,
and is equivalent to ANOVA for balanced designs. Restricted maximum likelihood
(REML) and maximum likelihood (ML) only differ when many fixed effects are
included in the model. Given that no fixed effects are included in the present
model, and that asymptotically the same distributions of the test statistic apply
for both methods, there would be essentially no difference between REML and
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ML for the present analysis. For ease of use the REML method was chosen
because it is packaged with LOKI, through a portal provided by QTL EXPRESS
(Seaton et al., 2002).
A secondary analysis was carried out on the region showing the most significant
linkage in the genome-wide scan. A threshold model was fitted using SOLAR
(Duggirala et al., 1997; Almasy and Blangero, 1998). The model takes into
account the dichotomous nature of the phenotype. SOLAR estimates IBD
probabilities using an algorithm based on applying regression formulae to results
from a marker specific IBD estimation algorithm. The SOLAR estimation method
has been shown to be less efficient (Sobel et al., 2001), and therefore SOLAR was
not used for the genome-wide variance component linkage scan.
2.2.7 Further genotyping in peak linkage region
Additional markers were added across the region with the largest LOD score
to maximise multipoint marker information content. In total, 16 microsatellite
markers and 20 SNPs were added across the linkage region. Several of the
additional microsatellite markers and the entire additional SNP marker set
were not placed on the ABI marker map. To obtain an accurate integrated
map on which all markers could be placed the Oxstats map was used (Kong
et al., 2002; Myers et al., 2005; Duffy, 2006). Markers were checked for genotyping
errors using PEDCHECK and CRIMAP. Erroneous markers were removed from
the analysis. Multipoint variance component analysis was carried out assuming
a threshold normal model in SOLAR.
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2.3 Results
2.3.1 Genotyping and error checking
Following CRIMAP flips analysis (Lander and Green, 1987) an alternative
position for marker D2S364 was given that was approximately 17,000 times more
likely than the one suggested by the ABI map. This marker was removed from
further analysis. CRIMAP flips analysis was re-run across chromosome two, and
no further markers gave a likelihood lower than -3.00. The given marker order
was accepted as a true representation of the marker sequence.
2.3.2 Parametric linkage analysis
The preliminary single-point linkage analysis identified 93 markers with a LOD
score greater than or equal to one (results not shown). An additional 59 markers
were placed in regions of low marker density on chromosomes 2, 3, 6, 7, 8, 10,
11, 12, 17, 19 and 20. Following the additon of further markers and the use
of estimated allele frequencies, 23 markers gave a LOD score greater than or
equal to 1.00. Only two of the additional markers gave a LOD ≥ 1.00. Table
(2.3.1) shows all markers with LOD score ≥ 1.00 following the addition of extra
markers. Table 2.3.3 shows ‘by family’ LOD scores for the 5 markers with
the highest single-point LOD scores identified by parametric linkage analysis.
The markers where LOD ≥ 1.00 were spread across 14 different chromosomes,
with the maximum single-point LOD score of 2.02 (marker D8S260) located on
chromosome 8q. This is above the genome-wide level for ‘suggestive linkage’
(LOD = 1.9, P = 0.0017) put forward by Lander and Kruglyak (1995).
Chromosome 14 contains a region of further interest because three markers
(D14S275, D14S288, D14S63), all within a 47cM interval spanning 14q11.2-
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Table 2.3.1: Parametric marker-specific linkage results for markers showing a
LOD score ≥ 1.00 in at least 1 family
Marker Model LOD score Family
D1S2841* Broad-dominant 1.17 364
D18S2800 Broad-recessive 1.01 226
D2S125 Narrow-recessive 1.37 ALL
D2S125 Broad-recessive 1.33 ALL
D4S2952 Broad-dominant 1.10 226
D4S1595 Broad-dominant 1.10 226
D4S1535 Broad-dominant 1.41 226
D4S2952 Narrow-recessive 1.25 ALL
D4S1595 Broad-recessive 1.13 226
D5S471 Narrow-recessive 1.11 ALL
D5S471 Broad-recessive 1.19 226
D7S516 Broad-recessive 1.20 ALL
D8S264 Narrow-recessive 1.15 ALL
D8S260 Narrow-recessive 2.02 ALL
D8S260 Broad-recessive 1.34 ALL
D10S1653* Broad-dominant 1.19 225
D11S904 Narrow-dominant 1.01 224
D11S904 Broad-dominant 1.01 224
D11S968 Narrow-recessive 1.03 224
D11S968 Broad-recessive 1.21 224
D12S324 Broad-dominant 1.04 226
D12S324 Broad-recessive 1.17 226
D14S275 Narrow-dominant 1.73 ALL
D14S275 Broad-dominant 1.55 ALL
D14S288 Broad-recessive 1.05 364
D14S63 Broad-recessive 1.32 226
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Table 2.3.2: Continued...
Marker Model LOD score Family
D16S3046 Broad-recessive 1.38 226
D16S3068 Broad-recessive 1.06 226
D17S1857 Broad-dominant 1.25 ALL
D17S1868 Broad-dominant 1.21 ALL
D20S107 Narrow-dominant 1.01 ALL
D20S107 Narrow-recessive 1.68 ALL
DXS1214 Narrow-dominant 1.70 ALL
ALL indicates a LOD score summated across all families. Markers giving a LOD
score ≥ 1.00 when using estimated allele frequencies but not with equal allele
frequencies are marked by *. Markers added in the second genotyping stage are
indicated by . The maximum LOD score is shown in italics.
14q23.3, produced a LOD score greater than or equal to a 1-LOD threshold.
Marker D14S70, which lies between D14S275 and D14S288, is the only marker in
this region not to show a LOD ≥ 1. There is no evidence against linkage at this
marker (LOD = -2), and the maximum LOD score at this locus is 0.56 under the
broad-recessive model. The maximum LOD score for marker D14S275 was seen
under the broad-dominant model, whereas for markers D14S288 and D14S263
the broad-recessive model produced the maximum LOD score.
2.3.3 Affecteds only parametric linkage analysis
‘Affecteds only’ parametric linkage analysis identified two further markers
(D2S325 and D7S510) with a LOD score greater than 1.00. Of the 30 markers
with a LOD ≥ 1.00 in the ‘full’ analysis, 10 produced a LOD score greater than or
equal to 1.00 in the affecteds only analysis. A summary of the ‘affected only’ LOD
scores is given in Table 2.3.4. Given that the linkage information provided by the
unaffected individuals has been removed, it is not surprising to see a reduction
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Table 2.3.3: Maximum LOD scores per-family for each of the five markers with
the highest LOD scores from marker-specific parametric linkage analysis
D8S260 D14S275 DXS1214 D20S107 D14S275
Family Model C Model A Model A Model C Model B
F224 0.85 0.91 1.22 0.45 0.92
F225 0.11 0.17 0.03 -0.02 0.30
F226 0.58 0.46 0.45 0.57 0.03
F364 0.47 0.19 0.00 0.68 0.29
Total 2.02 1.73 1.70 1.68 1.55
Model A = Narrow-Dominant, Model B = Broad-Dominant, Model C = Narrow-
Recessive. LODs greater than 1.00 are italicised.
in the number of LOD scores above a LOD-1.00 threshold. It is encouraging to
note that of the top 8 markers with LOD scores ≥ 1.00 under the ‘full’ analysis, 7
have LOD scores equal to or greater than 1.00 under the ‘affecteds only’ analysis.
This suggests that modelling the age-specific disease penetrance in unaffected
individuals introduced little bias to the results.
2.3.4 Non-parametric linkage analysis
Following the single-point parametric linkage analyses, a genome-wide non-
parametric variance component multipoint analysis was carried out. Results
are shown in Figure 2.3.1. Heritability estimates for MDD only and MDD or
unexplained swelling were 56% and 43%, respectively. Suggestive linkage peaks
are seen on chromosomes 7 and 14, under the narrow and broad definitions,
respectively. The linkage peak of 2.10 observed on chromosome 7 from variance
component analysis is approximately 28cM away from marker D7S516, which gave
a LOD score of 1.2 in the parametric linkage analysis (broad-recessive model).
Following the preliminary parametric genome scan further markers were added
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Table 2.3.4: MLINK marker-specific linkage results for markers showing a LOD
score ≥ 1 in at least 1 family following ‘affecteds only’ analysis
Marker Model LOD score Family
D1S2841 Broad-dominant 1.14 364
D2S125 Narrow-recessive 1.12 ALL
D2S325* Broad-recessive 1.43 ALL
D4S1535 Broad-dominant 1.00 226
D4S2952 Narrow-recessive 1.04 ALL
D7S510* Broad-dominant 1.10 ALL
D8S260 Narrow-recessive 1.35 ALL
D13S265 Narrow-recessive 1.23 ALL
D14S275 Broad-dominant 1.00 ALL
D14S288 Broad-recessive 1.05 364
D20S107 Narrow-dominant 1.00 ALL
D20S107 Narrow-recessive 1.67 ALL
DXS1214 Narrow-recessive 1.13 ALL
ALL indicates a LOD score summated across all families. Markers giving a LOD
score ≥ 1 under the ‘affected only’ analysis but not in the ‘full’ analysis are
marked by *. The maximum LOD score is shown in italics.
around D7S516. Markers D7S2427 and D7S519 are located under the variance
component linkage peak on chromosome 7. Neither marker D7S2427 nor D7S519
gave a LOD score greater than 1 under the parametric linkage analysis, with the
maximum observed single-point LOD scores being 0.97 (narrow-dominant model)
and 0.66 (broad-dominant model), respectively. The most interesting region
highlighted from the parametric linkage analysis was a 47cM region on 14q, which
contained three markers with a LOD score ≥ 1.00. This finding is supported by
variance component linkage analysis, which gave a broad peak across chromosome
14q, with a maximum LOD score of 2.68 (broad model) approximately 34cM from
the centromere. Under the narrow definition of disease the maximum LOD score
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was 2.50. Suggestive evidence for linkage was also found after fitting a threshold
model with Solar (LOD = 2.17). Sixteen microsatellite markers and 20 SNPs were
added across the linkage region on chromosome 14 to maximise the multipoint
marker information content in the region . A multipoint variance components
analysis was again carried out using SOLAR and a threshold model applied.
The maximum multivariate-normal multipoint LOD score after the inclusion of
the new markers was 1.56. Figure 2.3.2 shows the evolution of the chromosome
14 LOD score profile through the three stages of the study. The evidence for
linkage reduced substantially when the information on identity-by-descent was
maximised.
2.4 Discussion
This is the first genome-wide linkage study of major depressive disorder to
use a narrow definition of MDD classified by a comorbid non-psychiatric trait
(unexplained swelling). Suggestive evidence of linkage was found on chromosome
8q, which has previously been shown to contain bipolar affective disorder
predisposition locus (Cichon et al., 2001). Whilst the genetic links between
bipolar and major depression remain unclear it seems unlikely that the locus
identified in the present study is the previously identified bipolar locus. The
deCODE map places the bipolar locus at 124.62cM and the marker identified
in this study at 73.6cM. Both the 8q and 7p linkage regions identified in
this current genome scan are novel loci for major depressive disorder. On
chromosome 14 an initial variance component linkage peak of 2.60 (broad model)
was found at a position of 34cM from the p-terminal. Linkage at the region is
well supported by several analytical methods, with LOD ≥ 1 under parametric
analysis using narrow-dominant, broad-dominant, and broad-recessive models.
















































































































Figure 2.3.2: Evolution of linkage signals on the q-arm of chromosome 14.
Single-point parametric linkage analysis (narrow dominant model) = ◦.
Multipoint non-parametric genome-wide linkage analysis (Solar threshold
model) = red line. Multipoint non-parametric fine-mapping linkage analysis
(Solar threshold model) = green line. The original (red) and fine mapping
(green) markers and their positions on the ABI and intergrated (OXSTATS)
map, respectively, are given by |. The positions of the original markers on the
OXSTATS map are shown in blue. Both the original and additional markers
were used for fine mapping purposes.
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addition of fine-mapping markers the LOD score under a threshold model fell
to 1.52 (broad model). This is not unexpected for linkage analysis of complex
traits, but serves an important reminder that a number of promising LOD scores
in the range of, say, 2 to 3, may be false-positive findings. The power to detect
linkage depends on the sample size and the marker information. The current
sample size was fixed but the marker information content on chromosome 14
was maximised by adding more markers. The reduction in the test statistic
suggests that the chromosome 14 finding is a false-positive, however true linkage
to this region cannot be ruled out. Replication in other studies or the collection
of more families and/or a population-wide association study will ultimately
determine if chromosome 14 harbours one or more susceptibility genes for MDD
and comorbid unexplained swelling.
For parametric linkage analysis the population frequency of each disease and
marker allele is required for the calculation of the likelihood (Terwilliger and
Ott, 1994). When the genotype at a locus is known for each individual in the
pedigree, the specified allele frequencies at the locus have no effect on the LOD
score. However, allele frequencies are important when there are founders of
unknown genotype, and at loci where this is the case, the allele frequencies
will have an effect on the LOD score. In the majority of genome-scans there
are founders of unknown genotype at a given locus, and this is the case in the
current study. When all alleles at a locus were assumed to be equally frequent,
93 markers gave a LOD score greater than 1.00. Only 30 markers gave a LOD
score greater than one when allele frequencies were estimated from the genotyped
individuals within the pedigrees. This finding is consistent with that of Ott et al.
(1992) who found that choosing to use equal allele frequencies in a genome-wide
scan for linkage biases the LOD scores towards linkage when founders of unknown
genotype exist in the pedigree. Therefore, more attention should be paid to the
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LOD scores from the analysis with estimated allele frequencies. This analysis
still has limitations because allele frequencies were estimated from families
selected for depression and comorbid unexplained swelling and these may not
provide a true reflection of the true population allele frequencies.
The robustness of the parametric linkage analysis with regard to the estimated
model parameters was checked by providing multiple models for the analysis
of chromosomes 14 (the chromosome containing the maximum LOD score) and
chromosome 22 (the smallest chromosome). The alternative models provided
different penetrance, phenocopy rates and gene frequencies. Whilst the actual
LOD score and θ did vary, the test statistics for the markers remained consistent
relative to one another. That is to say that the marker which provided the
maximum LOD score on a given chromosome consistently did so, and only the
size of the test statistic differed. This result is encouraging, and suggests that
the markers identified through the parametric linkage analysis are not dependent
on the given model.
Linkage analysis was carried out using a parametric method so that the
age-specific penetrances of MDD could be modelled in unaffected individuals.
Furthermore, after viewing the disease transmission pattern in the four families,
it was assumed that a single variant of major effect was segregating in the four
families. In an attempt to increase power, most modern QTL linkage analyses
use multipoint methods. Multipoint methods use the genotype information of all
available markers simultaneously. The result is that multipoint methods increase
the information content at a given locus and thus increase the power to detect
linkage. In parametric linkage analysis the parameter which is estimated is the
recombination fraction (θ), and any model misspecifications lead to an inflated
θ being reported. With marker-specific linkage analysis we are interested in the
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LOD score at the marker, which remains unbiased in the presence of model
mispecifications provided dominance is correctly specified (Clerget-Darpoux
et al., 1986; Risch and Giuffra, 1992). However, incorrectly specified parameters
in multipoint linkage analysis can lead to biased LOD score estimates because
θ̂ is restricted by the marker map. For example, assume that the true θ = 0.1
but, due to model misspecifications, single-point linkage analysis gives a θ̂ of
0.3. If, using the same parametric model, multipoint parametric linkage analysis
was carried using markers spaced every 10cM (θ = 0.1) then the maximum
recombination fraction between the marker and disease is 0.1. Therefore, the
LOD score at the marker position with a single-point θ̂ of 0.3 will be lower in
the multi-point analysis than in the single-point analysis. Due to the problems
with defining accurate genetic models for complex diseases such as MDD, and
therefore the likelihood of biasing the LOD scores, a multipoint parametric
analysis was not carried out.
The aetiological and genetic link between depression and unexplained swelling
remains unknown. Whilst the large number of affected individuals within families
and the estimated heritabilities suggests a genetic cause, this remains uncertain.
The comorbidity of the diseases appears strong, with 59% of affected individuals
having both depression and unexplained swelling. Assuming that genetic loci are
involved in the aetiology of the disorder, the nature of these and their effects on
each individual phenotype remains unclear. Genes may have a primary effect on
only one of the phenotypes, with the second being a consequence of the primary
condition. It is a possibility that underlying genetic mutations have an effect on
a physiological pathway that leads to both depression and unexplained swelling.
Alternatively, the causative genetic loci could be in linkage disequilibrium with
each other and have effects on independent pathways leading to each separate
disorder.
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In conclusion, it is unlikely that a gene of major effect is segregating within
these four families with depression and comorbid unexplained swelling. Marker
D8S260 on chromosome 8q produced the maximum LOD score of 2.02 under a
narrow-recessive model. Modelling the age-specific penetrance in the unaffected




A simple grouped linear regression
method for linkage analysis of
censored traits
3.1 Introduction
Domestic animals and experimental species provide a unique resource for the
understanding of quantitative genetic variation. Quantitative trait analysis of
experimental crosses has provided many important insights into the genetics of
complex traits (reviewed in Andersson and Georges (2004) and Morgante and
Salamini (2003)). Several genes underlying quantitative genetic variation have
been identified in the fields of animal and crop science, many of which have
significant commercial potential (e.g. Jeon et al., 1999; Nezer et al., 1999; Frary
et al., 2000; Fridman et al., 2000; Grisart et al., 2002).
Most current quantitative trait loci (QTL) mapping techniques utilize an interval
mapping approach first put forward by Lander and Botstein (1989). The approach
places a hypothetical trait locus at fixed incremental positions (for example, every
1-2cM) along a map of known marker positions and tests for its effect on the trait
using information from flanking markers. For a given location the basic linear
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model is
yij = mj + eij, (3.1.1)
where yij is the trait value for individual i with genotype j, mj is the mean effect
of genotype j, and eij is random error (eij ∼ N(0, σ2e)). The genotype of an
individual at the position being tested is rarely known so the probability of an
individual being each of the possible genotypes is calculated from the available
marker information. Lander and Botstein (1989) implement their method using
a maximum likelihood approach. The maximum likelihood method takes into
account heterogeneous variances within marker classes to estimate genotype
probabilities. The model parameters are estimated under both the null (no QTL)
and alternative (with QTL) hypotheses. An advantage of maximum likelihood
is that it uses all of the available observations on marker genotypes and trait
values. The disadvantage of maximum likelihood is that it is computationally
intensive and usually requires specialized software.
An alternative method, least squares regression, uses expected genotype
probabilities calculated from flanking markers rather than the more complex
approximation via maximum likelihood (Haley and Knott, 1992). For this
approach least squares linear regression is used to estimate the effect of genotype
on the trait of interest at each test position along the genome. The asymptotic
equivalence of least-squares regression with maximum likelihood interval mapping
has been shown through simulation (Haley and Knott, 1992) and by theoretical
calculations of power (Rebai et al., 1995). The least squares approach has been
shown to be robust to deviations from normality in all but the most extreme
situations (Visscher et al., 1996; Rebai, 1997). Kao (2000) and Knott (2005)
review the differences between maximum likelihood and regression QTL mapping
methods.
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Time-to-event traits are often nonnormally distributed and show a right-skewed
distribution of trait values across all individuals. Additionally, time-dependent
traits often include censored observations, which occur when the true time of
the event is unknown. End-of-study censoring arises when the event of interest
has not occurred by the end of the study. Within-study censoring arises if
an individual is lost to follow-up during the course of the study. The loss of
information due to censoring results in lower statistical power, where the greater
the proportion of censoring the lower the statistical power. Some power can be
recovered by modeling censored individuals in the statistical analysis; however,
standard QTL mapping techniques typically do not account for this.
The field of survival analysis utilizes special methods to better use the information
provided by censored observations and account for the non-normal distribution
of the trait values. Traditionally, proportional hazard regression models are
used to model survival traits. These methods assume that if there are two
individuals, a and b, with p time-independent covariate values in vectors Za

















where h(t|Zi) is the hazard for individual i at time point t, h0(t) is the baseline
hazard function, and βi is the coefficient for the effect of the ith covariate.
As time dependence is only included in the baseline hazard, the ratio of the
hazards of two individuals at any time point is a constant and therefore the
hazards are proportional (Klein and Moeschberger, 1999). Cox (1972) proposed
a semiparametric proportional hazards model that can be used to model survival
data without pre-specifying the distribution of the baseline hazard. This
method is widely used and has been shown to be both robust and powerful.
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Parametric proportional hazard models also exist, which assume survival times
follow a given distribution (for example, Weibull). Under the correct baseline
hazard distribution, parametric models are more powerful than equivalent
nonparametric or semiparametric methods. However, when using real data,
the true underlying distribution of the baseline hazard is unknown. For this
reason, Cox proportional hazards regression remains the method of choice for
most survival analyses. Moreno et al. (2005) compared the Weibull and Cox
proportional hazards models to a more conventional QTL-mapping method that
ignored the nature of the survival data and found that when analyzing survival
trait data the proportional hazards models have greater power.
A drawback of both proportional hazards methods is that they are
computationally intensive for complex models. Models with many covariates,
some of which may be time dependent, can take extensive periods of time to
analyze. Several computationally intensive approaches have been proposed for
QTL mapping of survival traits in line crosses (Symons et al., 2002; Diao
et al., 2004; Diao and Lin, 2005) and outbred populations (Epstein
et al., 2003; Pankratz et al., 2005). All of these methods are yet to be
incorporated into general, widely used genome-analysis packages.
Here, a novel grouped linear regression method for the analysis of survival data
that is computationally simple, robust and can be implemented in standard
statistical packages is described. The method is compared to the classical Cox
and Weibull proportional hazards approaches and a standard linear regression
method that ignores censoring status. The relative power and robustness of the
method is demonstrated through simulation and the advantages of this simplified
method when compared to those currently available are discussed.
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3.2 Methods
The Cox proportional hazards model has been widely adopted as the method of
choice for survival analyses. However, when analyzing survival data with many
tied or grouped observations, or when analyzing large datasets, the Cox model
becomes computationally intensive. Grouped survival information is defined
as non-continuous survival time data. Prentice and Gloeckler (1978) extended
the popular Cox model for the analysis of grouped survival data. The method
correctly models grouped survival data but still remains computationally intensive
for large datasets. Here, a grouped approximation for continuous survival data is
proposed where failure times are partitioned into a number of time periods and a
linear regression model is put forward for the analysis of the grouped data. The
aim of this method is to simplify the analysis of continuous survival data leading
to reduced computation time and an increased ability to analyze models with
greater complexity. The survival of each individual through these arbitrary time
periods is coded using a series of conditional survival indicator variables, similar to
that used by Madgwick and Goddard (1989) to predict breeding values in dairy
cattle using lactation period survival data. Rather than adopt the maximum
likelihood approach of Prentice and Gloeckler (1978) for parameter coefficient
estimation a computationally efficient and robust linear regression method is put
forward. The simplicity and efficiency of the model should allow the analysis to
be carried out quickly on large datasets using standard statistical packages.
3.2.1 Grouped linear regression method
Survival times are sorted in chronological order, regardless of censoring status
or genotype, and separated into a predefined number of groups or time-periods.
The survival record for individual i during time period j is given by xij. If
individual i survives interval j, then the corresponding survival record is xij =
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Table 3.2.1: Example of the grouped linear regression group coding algorithm
for two time periods
Individual Survival Survival
record(s)
1 Censored during the first time period NA
2 Event occurs during the first time period 1
3 Survives the first time period, 0 1
the event occurs in the second
4 Survives the first time period, 0
then is censored during the second
0. If individual i experiences the event during interval j, then the survival record
is xij = 1 and there are no further survival records for the remaining intervals.
If an individual is censored during a particular interval then that individual has
no survival record for the current or subsequent intervals (Table 3.2.1). For any
given time period, the survival record represents the conditional probability that
an individual survives the current time period given that the individual survived
to the start of that time period. For any individual the survival records for
each group are therefore independent observations. The linear model used in the
regression analysis is given by
xij = β0 +
p∑
k=1
βktik + βggi + εij, (3.2.1)
where xij is the survival record for individual i during time period j, the β
terms are the estimated regression coefficients, tik is an indicator variable for
time period k that takes a value of 1 in time period j and 0 otherwise, gi is the
genotype for individual i, and εij is the random error for individual i during time
period j. The terms model the baseline hazard and βggi estimates the genotypic
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effect on the hazard. Only p-1 coefficients of ti can be estimated, as there are
no non-censored individuals surviving the last time period. The significance of
the effect of genotype is estimated using standard regression methodology. The
resulting F -statistic (with 1 and n-p-1 degrees of freedom, where n is the number
of individuals) is transformed to an approximate likelihood ratio test statistic
(LRT) using the formula provided by Baret et al. (1998),










to allow comparisons with the maximum likelihood test statistic of the
proportional hazards methods.
3.2.2 Simulation of data
Extensive simulations were carried out using the statistical software package R (R
Development Core Team, 2005). Genotypic data were simulated at a single locus
for individuals from a backcross between two fully inbred lines. Marker data were
generated at a single QTL locus with possible alleles q and Q, thus assigning an
individual the genotypes qq or Qq with equal probability. Phenotypic data were
simulated assuming a fully penetrant QTL at the marker locus. Phenotypic data
were drawn from a number of distributions (Table 3.2.2 and Figure 3.2.1). The













where ρ and λ are the shape and scale parameters, respectively. The probability
density of an exponential distribution, which is a special case of a Weibull
distribution where ρ = 1, is given by
f(t) = λ exp−(λ)t . (3.2.4)
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Table 3.2.2: Distributions used to simulate data
Genotype qq Genotype Qq
Model Distribution Shape (ρ) Scale (λqq) Shape (ρ) Scale (λQq)
1 Weibull 2.00 10.00 2.00 9.05
2 Exponential - 10.00 - 9.16
3 Gamma 3.65 2.19 3.65 2.43
4 Gamma 0.50 10.00 0.50 7.50







where Γ() is the gamma function.



















which is independent of time (t) and thus satisfies the assumptions of a
proportional hazards model. When considering model 1 (Weibull), individuals
with genotype Qq are at an increased risk of approximately 22% when compared
to the risk for genotype qq (for ρ = 2 and ρqq = 10, ρQq = 9.05). The mean of a
Weibull distribution is given by λ×Γ(1+ρ−1), where Γ() is the gamma function.
Thus, the simulated effect of the genotype on the hazard is equivalent to a mean
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Figure 3.2.1: The four distributions from which the survival times were drawn.
Figures generated by drawing 1000000 observations from each distribution.
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difference in survival time of (0.18 standard deviation units). The shape and
scale parameters of model 2 (exponential) were calculated to give the same ratio
of hazards as that of the Weibull parameters used in model 1 but from a more
highly skewed distribution. The parameters of model 3 (gamma) were chosen to
approximate the means and variances of the Weibull distributions used in model
1. To test the relative robustness of the methods when phenotypic data are
drawn from highly skewed distributions, data were simulated from two gamma
distributions where the gamma shape parameter was 0.5. Shape parameters were
chosen to approximate the hazard ratio used in model 1. The proportion of
censored individuals, Pc, was varied across simulations. For the generation of
censored observations the method of (Diao et al., 2004) and (Diao and Lin, 2005)
was implemented. Let Ti be the survival time of the ith individual, Ci is the
censoring time and I(Ci) is an indicator variable giving the censoring status (0 =
censored, 1 = uncensored) for individual i. Censoring times (Ci) were drawn from
a uniform distribution between 0 < x ≤ 1 and multiplied by a constant τ . Diao
et al. (2004) and Diao and Lin (2005) use a trial-and-error approach to obtain
τ . Here, the value of τ was calculated via numerical integration to provide a
given proportion of censored observations (see appendix 1). If Ci was less than Ti
then the individual was classified as censored (I(Ci) = 0) and the censoring time
was entered into subsequent analyses. Individuals with greater survival times are
more likely to be censored. The censoring method creates both “within-study”
and “end-of-study” of study censoring.
3.2.3 Analysis of simulated data
Two methods were used to group the observations (both censored and
uncensored) into time periods to investigate the robustness of the grouped linear
regression method to the grouping mechanism. The first grouping method (A)
groups the individuals into k groups such that an equal number of observations
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(either censored or uncensored) occur in each time period. The standard error
of the group means is approximately equal when using this method. The second
grouping method (B) groups the individuals into k groups such that an equal
proportion of individuals, denoted by s, survive each time period. Within-group
variances are approximately equal when using this method. For both methods the
last time period contained all remaining individuals not previously experiencing
the event of interest. For example, with 1000 individuals and five time periods,
grouping mechanism A creates five groups of 200 individuals, while grouping
method B with s = 0.5 creates groups of 500, 250, 125, 63, and 62 individuals.
The change in mean test statistic in relation to the number of time periods and
the proportion of individuals surviving each time period was investigated for each
grouping mechanism.
3.2.4 Power comparisons
The power of the grouped linear regression method was compared to that
of the Cox and Weibull proportional hazards models and the standard linear
regression least squares approach (ignoring censoring status). The inclusion of
the standard linear regression method allows some approximation of the power
to be gained by including the censored observations correctly in the regression
model. Grouping method B was used to separate the continuous survival times
into groups for the grouped linear regression method. Values were chosen for the
grouping parameters that approximately maximized the power of the grouped
linear regression method. Methods were contrasted by comparing the mean test
statistic from each mode of analysis given phenotypic data drawn from the same
underlying distribution. To ensure this was an unbiased comparison of methods,
1000 simulations of 1000 individuals were carried out under the null hypothesis
for each mode of analysis. Deviations from a chi-squared distribution with one
degree of freedom were tested for using a one-tailed Kolomonov-Smirnov test.
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Where a significant deviation from a chi-squared distribution was seen for a given
phenotypic distribution, analysis methods were compared via empirical P -values.
To calculate the empirical thresholds 10000 replicates of 1000 individuals were
simulated under the null hypothesis. The proc.time( ) function in R was used to
obtain run times for the model-fitting step of each mode of analysis.
3.2.5 Alternative censoring mechanisms
For the above simulations, only the τ censoring mechanism of Diao et al. (2004)
and Diao and Lin (2005) was used. Two alternative censoring mechanisms were
applied to further investigate the relative powers of the mapping methods and
their robustness to the censoring mechanism. The first alternative censoring
mechanism, random censoring, simulates censoring status (I(Ci)) by drawing
from a Bernoulli distribution with probability 1-Pc. If I(Ci) = 0 (i.e. the
individual is censored) then the censoring time (Ci) is given by (Ci) = xTi,
where x is a random uniform number between 0 and 1. This method censors
individuals randomly, irrespective of survival time. Specifically, those individuals
surviving longer are at no increased risk of being censored. The random censoring
mechanism only creates “within-study” censoring. The second alternative
censoring mechanism, here named Weibull censoring, draws censoring times (Ci)
from a Weibull distribution with shape parameter ρ and scale parameter λc. The
value of λc is calculated to provide a given proportion of censored observations
(see Appendix 2). If Ci is greater than Ti then the individual is classified as
uncensored (I(Ci) = 1). If Ci is less than Ti then the individual is classified
as censored (I(Ci) = 0) and the censoring time is used in subsequent analyses.
Unlike the random censoring method, individuals with greater survival times are
more likely to be censored. The Weibull censoring mechanism creates “within-
study” censoring.
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Table 3.3.1: Grouping method A: grouped linear regression mean test statistic
Censoring Number of groups (k)
proportion (Pc) 2 3 4 5 6 7 8 9 10
0 1.94 7.70 8.24 8.76 9.42 9.28 9.55 9.32 9.87
0.1 1.91 6.72 7.14 8.26 8.44 8.48 8.91 8.98 8.80
0.5 3.13 5.22 5.04 5.67 5.68 5.49 5.83 5.80 5.84




Tables 3.3.1, 3.3.2, and 3.3.3 show the effect of altering the group survival
proportion (s) and/or the number of groups (k) on the grouped linear regression
mean test statistic. The shape and scale parameters of model 1 (Weibull) were
used in the simulations. Some combinations of s and k are impossible with
a sample size of 1000 individuals as the number of individuals in a group falls
rapidly at low values of s, thus limiting the possible number of groups (k). For the
range of groups simulated, the mean test statistic approximately increased with
the number of time periods into which the data were grouped. This result was
seen for both grouping methods. An increase in mean test statistic was seen when
comparing grouping method B to grouping method A. This relationship only held
if the optimal group survival proportion was determined correctly for grouping
method B. However, this may not always be possible, in which case adopting a
grouping method in which each group contains an equal number of individuals (A)
leads only to a small reduction in mean test statistic. When the same proportion
of individuals survive each group (grouping method B) the lowest possible group
survival rate, given the number of time periods and sample size, gave a reasonable
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Table 3.3.2: Grouping method B: grouped linear regression mean test statistic
with no censoring
Group survival Number of groups (k)
proportion (s) 2 3 4 5 6 7 8 9 10
0.1 5.38 7.09 - - - - - - -
0.2 4.91 8.50 - - - - - - -
0.3 3.85 9.02 9.39 - - - - - -
0.4 2.85 8.85 9.72 10.18 10.24 - - - -
0.5 1.94 8.13 9.54 10.15 10.66 10.78 - - -
0.6 1.21 7.17 8.68 9.62 9.97 10.25 10.69 10.76 10.74
0.7 0.65 6.18 7.41 8.56 9.03 9.90 9.99 10.36 10.43
0.8 0.35 4.52 5.71 6.94 7.72 8.05 8.77 9.48 9.45
0.9 0.10 2.89 3.56 4.55 5.23 5.76 6.18 6.83 6.93
Italics depict the maximum mean test statistic for the given group survival
proportion (s).
approximation to maximize the mean test statistic. For the power comparisons
grouping method B was adopted, where an equal proportion of individuals (s =
0.6) survived each of the groups (k = 10). These parameters will not maximize
the mean test statistic in all situations, but provide a good approximation to
the optimal parameters in the situations tested and good practical guidelines for
other studies of similar size.
3.3.2 Power Comparisons
The distribution of test statistics for all four modes of analysis was shown to be
chi-squared under the null hypothesis for model 1 (Figure 3.3.1). This supports
the use of the mean test statistic as an unbiased parameter for the comparison
of methods. Figure 3.3.2 shows the mean test statistic for all four modes of
analysis with varying percentages of censored survival times. In the absence
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Table 3.3.3: Grouping method B: grouped linear regression mean test statistic
with 50% censoring
Group survival Number of groups (k)
proportion (s) 2 3 4 5 6 7 8 9 10
0.1 3.46 3.99 - - - - - - -
0.2 3.23 5.04 - - - - - - -
0.3 2.66 5.06 5.29 - - - - - -
0.4 2.16 4.81 5.42 5.34 5.62 - - - -
0.5 1.78 4.72 5.04 5.45 5.69 5.97 - - -
0.6 1.61 3.97 4.65 5.23 5.23 5.69 5.62 5.63 5.81
0.7 1.29 3.26 3.93 4.37 5.13 5.32 5.48 5.83 5.76
0.8 1.10 2.34 3.23 3.68 3.91 4.32 4.65 5.13 5.28
0.9 1.07 1.51 1.93 2.38 3.61 2.79 3.09 3.39 3.80
Italics depict the maximum mean test statistic for the given group survival
proportion (s).
of censoring the four analysis method have approximately equal power. The
standard linear regression model has a slightly reduced mean test statistic when
compared to the survival analysis methods. This difference is likely due to the
non-normal distribution of the survival times. As the percentage of censored
observations is increased, the standard linear regression mean test statistic falls
rapidly. In comparison, that of the grouped linear regression and Cox and
Weibull proportional hazard models decreases at a slower and comparable rate.
The relative and actual run-times from the model fitting step of each analysis
method are shown in Table 3.3.4. The procedure time for fitting 100 models
showed the grouped linear regression method to be almost five times quicker
than the Cox proportional hazards method and over twelve times quicker than
the Weibull proportional hazards method.
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Figure 3.3.1: Q-Q plots for phenotypes simulated from model 1 (Weibull) under
the null hypothesis. Dashed line denotes the 1:1 relationship between sample
and theoretical percentiles. P -values from a one-tailed Kolomonov-Smirnov
test.
Figure 3.3.2: Mean test statistics for phenotypes simulated from model
1 (Weibull) distributions with varying proportions of censoring. 2,
grouped linear regression; ×, Cox proportion hazards regression; +, Weibull
proportional hzards regression; 3, standard linear regression.
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Table 3.3.4: Time taken to fit 100 models using R (v.2.1.1)
Relative procedure Actual procedure
time time (sec)
Standard linear regression 1 0.22
Cox proportional hazards regression 7.2 1.59
Weibull proportional hazards regression 19 4.18
Grouped linear regression 1.5 0.33
aNumber of groups (k) = 10, group survival proportion (s) = 0.6
When simulating data under the null hypothesis from model 2 (exponential)
no significant deviations were detected from a chi-squared distribution with
one degree of freedom (Figure 3.3.3). When comparing the relative mean test
statistics from model 2 (exponential), similar relationships to those under model
1 (Weibull) were observed (Figure 3.3.4). Given that an exponential distribution
is a special case of a Weibull distribution, when ρ=1, it is not surprising to
find that the parametric Weibull proportional hazards method is of equal power
when compared to the Cox proportional hazards model.
When phenotypic data were simulated under the null hypothesis using model
3 (gamma), a significant deviation from a chi-squared distribution (p = 0.012)
was seen when using the Weibull proportional hazards model (Figure 3.3.5).
This result was not unexpected as the Weibull proportional hazards model fits
a Weibull distribution to the distribution of survival times, which in this case
follow a gamma distribution. To make unbiased comparisons between the four
analysis methods empirical P -values were calculated for each method of analysis
(Figure 3.3.6). When the phenotypes contained no censored observations the
best-performing model was standard linear regression. This is not surprising
as a gamma distribution with a shape (ρ) of 3.65 is not highly skewed. The
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Figure 3.3.3: Q-Q plots for phenotypes simulated from model 2 (exponential)
under the null hypothesis. Dashed line denotes the 1:1 relationship between
sample and theoretical percentiles. P -values from a one-tailed Kolomonov-
Smirnov test.
Figure 3.3.4: Mean test statistics for phenotypes simulated from model
2 (exponential) distributions with varying proportions of censoring. 2,
grouped linear regression; ×, Cox proportion hazards regression; +, Weibull
proportional hzards regression; 3, standard linear regression.
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worst-performing model under no censoring was the Weibull proportional hazards
model. This is most likely due to the incorrect parameterization of the baseline
hazard. As the proportion of censoring is increased the three survival analysis
methods outperform the standard linear regression method. The grouped linear
regression method shows the same power as the Cox proportional hazards method.
The gamma distributions used for model 3 were not highly skewed. However,
under the highly skewed gamma distributions of model 4 a similar pattern is
seen. When analyzing data simulated under the null hypothesis the Weibull
proportional hazards model again gives test statistics which are not distributed as
a chi-squared distribution with one degree of freedom (p = 0.0007) (Figure 3.3.7).
With no censoring in the sample simulated under the alternative hypothesis
the Weibull proportional hazards method is the least powerful mode of analysis
(Figure 3.3.8). Again, the grouped linear regression approach is of equal power
to the Cox and Weibull proportional hazards models, regardless of the censoring
proportion. When simulated phenotypes include censored observations, the least
powerful method was the standard linear regression method.
To further check the robustness of the method, two alternative censoring
mechanisms were simulated. Both the random and Weibull censoring methods
only simulated “within-study” censoring. No differences in the relative powers of
the methods were observed (Figures 3.3.9, 3.3.10). When censored observations
were simulated using the random censoring mechanism the relative power of the
four analysis methods changes when 70% or more of the observations are censored.
Given that few studies attempt to analyse datasets with more than 70% censored
observations this result seems insignificant.
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Figure 3.3.5: Q-Q plots for phenotypes simulated from model 3 (gamma) under
the null hypothesis. Dashed line denotes the 1:1 relationship between sample
and theoretical percentiles. P -values from a one-tailed Kolomonov-Smirnov
test.
Figure 3.3.6: Mean test statistics for phenotypes simulated from model 3
(gamma) distributions with varying proportions of censoring. 2, grouped
linear regression; ×, Cox proportion hazards regression; +, Weibull
proportional hzards regression; 3, standard linear regression.
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Figure 3.3.7: Q-Q plots for phenotypes simulated from model 4 (gamma) under
the null hypothesis. Dashed line denotes the 1:1 relationship between sample
and theoretical percentiles. P -values from a one-tailed Kolomonov-Smirnov
test.
Figure 3.3.8: Mean test statistics for phenotypes simulated from model 4
(gamma) distributions with varying proportions of censoring. 2, grouped
linear regression; ×, Cox proportion hazards regression; +, Weibull
proportional hzards regression; 3, standard linear regression.
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Figure 3.3.9: Mean test statistics for phenotypes simulated from model 1
(Weibull) distributions with varying proportions of random censoring. 2,
grouped linear regression; ×, Cox proportion hazards regression; +, Weibull
proportional hazards regression; 3, standard linear regression.
Figure 3.3.10: Mean test statistics for phenotypes simulated from model 1
(Weibull) distributions with varying proportions of Weibull censoring. 2,
grouped linear regression; ×, Cox proportion hazards regression; +, Weibull
proportional hzards regression; 3, standard linear regression.
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3.4 Discussion
It has been shown empirically that assuming the Xij values are Gaussian does
not have a negative impact on power, at least not for the range of parameters
that were considered. This is most likely because in a backcross experiment
the test statistic for linkage comes from a difference in the marker means and,
because of the central limit theory, these are asymptotically normally distributed
(Visscher et al., 1996). The assumption about the distribution of the Xij values
may be less good for extreme survival probabilities and in outbred populations
in which the test statistic is based on the estimation of a variance component.
The grouped linear regression method is not only as robust and powerful as
the Cox proportional hazards method but also computationally much faster.
For genome-wide scans of several thousand test positions and many potential
models, the saving in computation time would be considerable. The reduction in
computation time would be further appreciated when carrying out permutation
testing or bootstrapping. For example, consider a genome of 3000 cM with
linkage analysis carried out at intervals of 1cM. If one was to carry out 1000
permutation tests on the sample then the grouped linear regression method,
assuming the relative times are the same as shown in these simulations, would
be 10.5 hours faster than the Cox model and 32 hours faster than the Weibull
proportional hazards method. The exact savings in computation time will vary
as the computation times given here for each model are estimates and will vary
between software packages. The number of individuals in a study, the number
of groups into which the continuous survival times are split and the proportion
of tied observations in the sample are expected to have an effect on the relative
run times of the various methods. Direct comparisons have been made between
methods that all utilize the expected genotype probabilities at a given point
when testing for a QTL at that location. Therefore, in terms of computation
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time, all these models have an advantage over those models that fit a more
complete, and computationally complex, maximum likelihood mixture model
approach, such as the methods of Symons et al. (2002), Diao et al. (2004),
or Diao and Lin (2005). Further savings in computation will be seen when
comparing the grouped linear regression method to these maximum likelihood
models.
Recently, Moreno et al. (2005) compared the power of the Weibull and Cox
proportional hazards methods to standard Gaussian methods for mapping
QTL in survival traits. Empirical survival times for an F2 population were
sampled from a real dataset collected on salmonella resistance in mice. Data
were transformed differently for each analysis method. Differing proportions of
additive/dominance effects and censoring proportions were simulated. When
censored observations were included in the sample, Moreno et al. (2005) report
a significant difference in power between the proportional hazard models and
standard linear regression methods for all simulation sets. This is consistent
with the findings here. Moreno et al. (2005) also report a significant difference
in power between the proportional hazards methods and standard QTL mapping
methods when all observations are fully observed. This relationship was most
significantly observed with an additive effect of .30 and an absence of dominance
effects. Proportional hazards methods approximately provided a power of .60
while standard QTL mapping methods provided a power of .42 at the 95%
level. Moreno et al. (2005) report that for larger additive effect sizes, and in
the presence of dominance, the difference between the proportional hazards and
standard QTL mapping methods disappears. In the present study when data
were simulated using model 1 (Weibull), a slight reduction in the mean test
statistic was observed for the standard linear regression method compared to
that of the survival analysis methods. This reduction was much less marked than
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that reported by Moreno et al. (2005). When uncensored data were simulated
from model 2 (exponential) no significant differences in mean test statistic were
detected when comparing the standard linear regression method to the survival
analysis methods. Furthermore, when data were simulated from a gamma
distribution with no censoring, the standard linear regression method was shown
to have the most power at the 95% level. Reducing the effect of the QTL on
the hazard to 3% (increased risk for genotype Qq when compared to that of
qq) allows a more direct comparison to the simulations performed by Moreno
et al. (2005). The reduction in QTL effect size dropped the power to detect
linkage to approximately 0.6 at the 95% level, similar to the power achieved
by Moreno et al. (2005). No significant difference was observed between the
power of proportional hazards or standard methods. In addition, no differences
in the power to detect linkage were seen using either a proportional hazards
framework or a standard QTL mapping procedure when simulating from Weibull
distributions with shape ρ = 4 or ρ = 6. Due to the way in which Moreno
et al. (2005) simulated and transformed phenotypic data it is difficult to further
examine the difference between the two study findings.
The grouped linear regression method uses binary survival indicators similar
to those used by Madgwick and Goddard (1989). A grouped approach was
natural for their dataset as it consisted of survival through a series of different
lactation periods, which are pre-defined, biologically relevant time periods. A
similar method was adopted by Meuwissen et al. (2002) to estimate breeding
values for functional survival, in a simulated dairy cattle dataset. The authors
compared both a linear and logistic regression method to a proportional hazards
model and found no significant difference in estimated breeding value. In this
study, a grouped linear regression method has been developed for survival traits
with a continuous distribution. It has been shown that if a sufficient number
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of time periods are chosen then little is lost in the way of power by grouping
the data. The conditional survival probabilities (group survival indicators)
are directly related to the hazard for a particular interval. Asymptotically,
with many time intervals and a large number of observations per group, the
conditional survival probabilities, scaled by the probability of survival until that
time, are simply discrete versions of the continuous hazard. Just as the hazard
function is a continuous approximation of a discrete observation (survival or
death at a particular point in time), so the grouped approximation is a discrete
approximation of a continuous distribution. With the grouped linear regression
model the effects on the hazard are additive, whereas the usual assumption of
proportional hazard models is that the effects act in a multiplicative manner.
If the intervals are chosen such that the conditional survival probabilities in
different time intervals are the same then the multiplicative and additive models
converge.
The power of the grouped linear regression method was maximized, via
simulation, prior to the comparative power analysis. However, the gain in
power achieved by this is small. Most non-extreme values of s and k closely
approximate the power provided by the optimal values. While it would be
possible to carry out this optimization step before analyzing real data, it could
be of relatively little benefit and time consuming. Thus, the robustness of the
grouped linear regression method to the chosen number of time periods and
group survival probability is encouraging.
Current mapping methods require specialized software for genome-wide linkage
methods. The grouped linear regression method uses standard linear regression
methodology and thus can be implemented in many of the widely available
statistical packages, including the freely available R that was used here.
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Expanding the grouped linear regression method to a genomewide level is
straightforward. The ability to analyze genomewide marker data for linkage in
freely available and easy to use packages is significant, especially if this can be
done with little or no sacrifice in power.
In this study a backcross population was simulated; however, the extension of
the method for other line crosses is relatively simple. Furthermore, it should be
possible to extend the method to more complex situations such as the mapping
of QTL with potentially censored data in outbred populations. Current methods
for the mapping of QTL using censored data in general outbred populations
are limited. Unlike in inbred lines where the QTL effect is fixed in both
populations, not all individuals in an outbred population will segregate a given
QTL. Furthermore, unlike fully inbred lines, each individual has a different
genetic background effect. A random-effects QTL model based upon multiple
0/1 indicator variables would naturally fit into a linear mixed model framework
and would allow QTL analyses in general pedigrees when a proportion of
observations are censored.
In summary, a computationally efficient and fast method for the analysis of
continuous survival data has been suggested. The grouped regression method is of
equal power when compared to other available methods and is robust to changes
in censoring proportion and mechanism and to the underlying distribution of the
phenotype.
3.5 Appendix 1: Tau Censoring
Here, a value for the parameter τ used in Tau censoring mechanism is derived.
For a general distribution of times to events, f(T ), a value of τ is required such
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that a random uniform variable between 0 and τ is less than a random value for
T with a probability Pc. The general solution to this problam is
P (T > C) = ET (P (T > C|C)) =
∞∫
0
f(T )P (T > C|C)dT = Pc (3.5.1)
where C is the random censoring time. The probability P (T > C|C) is calculated
noting that all values of T above τ are censored. Thus,








; T < τ
1; T ≥ τ.
(3.5.2)
It follows that












Tf(T )dT = Pc
(3.5.3)
For the cases of the Weibull and gamma examined in this chapter, the value of
the τ is solved by numerical integration.
3.6 Appendix 2: Weibull Censoring
Here, a value for the scale parameter, λc, used in the Weibull censoring mechanism
is derived. Firstly, consider the case where no QTL effect is present. The





























such that the probability that a random value of C is less than a random value
of T at a pre-defined probability Pc (i.e. an observation will be censored with
probability Pc).
Thus, solve






g(C)dCdT = Pc (3.6.3)
for λc. This calculation can be simplified by noting that if X is distributed as a
Weibull variable with parameters ρ and λ, then Xρ is exponentially distributed
with parameter λρ. As this power transformation is one-to-one, the required
integral reduces to
P (T > C) = P
(


























































which is readily solved for λc.
When a QTL effect is present, the probability distribution of the time to event































In this case, the relevant equation for Pc is
P (T > C) = P
(





































from which the positive solution is used in generating censoring times.
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Chapter 4
Estimation of variance components
for age at menarche in twin families
4.1 Introduction
As discussed in the previous chapter, the semi-parametric Cox proportional
hazards method remains the method of choice for most survival analyses.
However, the Cox model relies on the survival times of individuals being
independent, and this is not always the case. Individuals can be grouped in such
a way that their survival times become correlated. For example, individuals
could belong to the same family. If this were the case, and there was a common
environmental effect on survival time, then one would expect the survival times of
family members to be correlated. If the Cox model is applied to non-independent
data then the model parameters are overestimated (Wei et al., 1989). Special
methods are needed to analyse data when survival times are correlated.
Frailty models have been derived to model non-independent survival data. A
frailty is an unobserved random effect which acts multiplicatively on the baseline
hazard. A shared frailty is a random effect which is the same for all members of a
group, for example a family effect (Xue and Brookmeyer, 1996). With this model,
families with a large frailty will experience the event earlier than families with
a small frailty. The model therefore allows for the presence of both ‘frail’ and
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‘robust’ families (Klein and Moeschberger, 1999). However, for genetic studies,
fitting only a single family effect is unappealing as people within a family are
related to differing degrees. To model the genetic relationship of individuals
within a family a correlated frailty method must be adopted. These methods
fit a per-individual random effect which is correlated according to a relationship
matrix. The relationship matrix denotes the degree of genetic relatedness for
all pairs of individuals within a family. It is the variance-covariance matrix of
the additive genetic random effects. Each off-diagonal element is the additive
genetic coefficient of relatedness for that pair, which is equal to twice the kinship
coefficient (Lynch and Walsh, 1998). In a non-inbred population, the diagonals
of this matrix are 1. For example, in a family of three siblings, a 3x3 matrix
would show the covariance of the siblings to be 0.5 (the matrix off-diagonals)
and the variance of each sibling to be 1 (the matrix diagonals). Therefore, the
dependency between individuals is fully accounted for by the random effects in
the model. While most random effects methods assume that the frailties follow a
gamma distribution, a Gaussian random effects model is most easily generalised
to arbitrary covariance matrices. Ripatti and Palmgren (2000) proposed a mixed
effects Cox model which includes both fixed and random effects and is given by
λ(t) = λ0(t) exp
Xβ+Zb (4.1.1)
where λ0(t) is the baseline hazard, X is a fixed effect matrix, Z is a random
effect matrix and β and b are the corresponding parameter vectors.
Like the traditional Cox model, the mixed effects Cox model is semi-parametric
and does not require the distribution of the baseline hazard to be specified. In
addition, the model retains the proportional hazards framework as it is assumed
that the conditional individual-specific hazards are proportional over time. The
model can be applied to estimate variance components in outbred populations. If
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an IBD matrix and a relationship matrix are included as random effects matrices,
the model can also be used for mapping QTL in outbred populations. An IBD
matrix is a realised version of the additive genetic relationship matrix at a given
locus. It is the covariance matrix of the random QTL effects at that locus.
Off-diagonal elements are half the probability that a pair shares 1 allele identical
by descent (IBD) plus the probability that the pair shares 2 alleles IBD. In a
non-inbred population, these elements are equivalent to the proportion of alleles
shared IBD between the pair. Diagonals are equal to unity. Using this statistical
model, Zhao (2005) found that marker D4S1645 contributed significantly to the
variance in alcohol dependency in 143 Genetic Analysis Workshop 14 families
drawn from the Collaborative Study on the Genetics of Alcoholism.
In this chapter, the age at onset trait of interest is age at menarche (AAM). Age
at menarche, the time of first menstrual period, is an important developmental
milestone in females and is a clearly defined event in the course of female
pubertal development. Age at menarche is also thought to be an important
evolutionary trait (Kirk et al., 2001).
Age at menarche is a complex trait which is determined by an array of genetic
and environmental factors. Several twin studies have been carried out to
partition inter-individual trait variation in age at menarche into genetic and
environmental components and their findings are summarised in Table 4.1.1.
This is an important first step in understanding the genetics of a trait, and
one which should be carried out prior to gene mapping experiments. Genetic
factors clearly play a role in age at menarche, with monozygotic (MZ) twin
correlations in the range of 0.51-0.95, and dizygotic (DZ) twin correlations in
the range of 0.17-0.58 corresponding to heritabilities in the range 0.30-0.95.
Studies which make use of other family structures support these findings. A
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recent study of age at menarche, carried out using family data from the Fels
Longitudinal Study (Roche, 1992), reported a heritability (h2) of 0.49 (95% CI =
0.24-0.73) (Towne et al., 2005). The study analysed data from 371 white females
from extended families and found not only a significant genetic effect on age
at menarche, but also a year of birth effect that explained 0.02 of the residual
phenotypic variation. A recent twin study has suggested that common genes
(but different environments) influence the sequence of pubertal events (van den
Berg et al., 2006) of which age at menarche is the most readily scored.
Of the six twin studies described in Table 4.1.1, three were carried out on
adolescent samples. Kaprio et al. (1995) collected age at menarche data from
323 Finnish twin pairs who were within 3 months of their sixteenth birthday
at the time of data collection. No censored observations were present in the
sample. Loesch et al. (1995) analysed age at menarche data from a small
sample of adolescent twin pairs from Poland. The twins were examined annually
throughout adolescence, up to the age of 18. As a result of the long period of
follow-up, no censored observations were present in the sample. van den Berg
et al. (2006) recruited two cohorts of twins with average ages of 12.2 years and
12.4 years, respectively. Due to the young age of the twins, the two cohorts
contained many censored age at menarche observations, with the first and second
cohorts having 86% and 74% censored individuals, respectively. Neither of the
Dutch cohorts were followed-up to remove the censored observations from the
sample.
It is important to use age at menarche data collected from adolescent samples
when carrying out genetic analysis of age at menarche because reports of age
at menarche in adult samples have been shown to be inaccurate. In a sample

















































































































































































































































































































































































































































































































































































































correlation between actual and recalled age at menarche of 0.78 when recall was
requested approximately 19 years post-menarche. When recall was attempted 39
years post-menarche the correlation coefficient between actual and recalled age
at menarche was 0.6 (Damon and Bajema, 1974). Koo and Rohan (1997) showed
that even over a period of three years the accuracy of age at menarche recall
decreases. They reported that after an interval of 1-2 years only 59% of females
could recall the exact year and month of their menarche, whilst 77% of women
were accurate to within one month. If, in an attempt to remove the recall bias
of adult samples, one ascertains adolescent samples then a large proportion of
the sample could be yet to experience menarche (van den Berg et al., 2006). A
study design which both uses adolescent females and has sufficient follow-up to
remove censoring is therefore required for accurate studies into the genetics of age
at menarche. To date, the only prospective and longitudinal twin study that has
been carried out to look at the genetics of age at menarche is the Loesch et al.
(1995) study, and this only had a sample size of 44 MZ and 42 DZ twin pairs.
4.2 Methods
In the present study, a sample of adolescent MZ and DZ pairs, and their siblings, is
used to partition the variance of age at menarche into genetic and environmental
components. The adolescent twins were first seen close to their 12th birthday and
followed up at ages 14 and 16, so the age at menarche data should be accurate and
contain only a small proportion of censored individuals. Two methods are used to
partition the variance of age at menarche into underlying components: a standard
method which does not statistically account for the censored observations in the
data, and a correlated frailty model which does account for the censored nature
of the data.
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4.2.1 Adolescent twin families
Adolescent twins and their families were recruited for an ongoing study of
melanoma risk factors at Queensland Institute of Medical Research, Australia.
Twins were interviewed at ages 12 and 14. Non-twin siblings were asked to
attend the interview if they were more than ten years old and had not previously
attended (i.e. the siblings attend the clinic for interview once only). As part
of the clinical protocol, described by Zhu et al. (1999), female adolescents were
asked during interview to provide the date of their first menstrual period. Date
of first menstrual period and date of birth were used to calculate the age at
menarche for each individual (in months). Two age at menarche measures were
potentially available for the twins who attended both the age 12 and age 14
interviews. For individuals with repeat observations the correlation between the
age at menarche reported at age 12 and that given at age 14 was calculated.
The present analysis uses age at menarche data collected between May 1992 and
February 2006.
A second sample of adolescent twin families was recruited to an ongoing study of
cognitive ability, again at Queensland Institute of Medical Research, Australia.
Twins were interviewed at age 16, with siblings asked to attended if they were
10 years of age or older. As part of the clinical protocol, described previously
by Wright et al. (2001), female participants were asked by a research nurse
to provide the date of their first menstrual period. The same procedure as
implemented in the melanoma risk factor study was used to calculate the age
at menarche. A subset of the 16 year old cohort (324 individuals) was asked,
via a telephone interview at a later date, to give their age at menarche. These
individuals attended for interview before age at menarche data was introduces
as part of the cognitive ability study protocol. This current analysis uses age at
menarche data collected between July 1996 and February 2006.
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Where two or more age at menarche estimates were available for an individual,
the estimate provided at the first data collection following menarche was used.
It was assumed that the recall closest in time to menarche would be the most
accurate. The date of interview was recorded for all individuals. If an individual
was censored (i.e. the true age at menarche was unknown because the individual
had not started menstruating at the time of last interview), the age at last
interview was used in the analysis.
For ease of computation, 30 females were removed from the data set because
they were either the last born member of a triplet or members of a second
twin pair. In total, the data consisted of age at menarche information for 1,351
adolescent twins and their siblings, 226 (16.73%) of whom had a censored age at
menarche. Univariate outliers were identified as individuals reporting an age at
menarche less than 104 or greater than 208 months. In total, 6 individuals were
identified as outliers and removed from further study.
Siblings were asked to attend the clinic for interview if they were 10 years of age
or above. Twins attended the clinic for interview at ages 12, 14 and/or 16. It
is likely that a 10 to 12 year old sibling would not have started menstruating,
and therefore would be censored for age at menarche. In this scenario, the
age at last seen (10-12 years) was used as an age at menarche. The minimum
censored age at menarche (age at last seen) for a twin is 12 years. Not only
can siblings attend the clinic at a younger age than the twins, but they can
also attend when older than 16 years of age. The range of the censored age at
menarche estimates in the siblings and twins is 116 to 208 months and 144 to
194 months, respectively. The presence of siblings older than 16 years will have
a lesser effect on the age at menarche variance because it is unlikely that these
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individuals will be censored. Thus, the age at last seen was not used for these
individuals. However, given the findings of Koo and Rohan (1997) regarding
the reduction in age at menarche recall accuracy over a period of 1-2 years,
it is likely that older siblings provided a less accurate estimate of age at menarche.
To ensure that all individuals within the study had the same opportunity to
experience menarche, the siblings with an age at interview of less than 12 years
were removed from the study. A total of 223 non-twin sisters, including 21 sibling
pairs, had an age at interview greater than 12 years. The final sample consisted of
1,302 adolescent females, 184 (14.13%) of whom had a censored age at menarche.
4.2.2 Estimation of variance components
Twin pair correlations can be used to decompose inter-individual trait variation
into genetic and environmental components. Inferences are based on the genetic
similarity of monozygotic versus non-monozygotic (DZ twins and siblings) twin
pairs; monozygotic twins share all their genes in common and non-MZ pairs
share on average half their genes in common. When the phenotypic correlation
between monozygotic twin pairs is greater than that of non-MZ twin pairs,
it is assumed that genetic influences underlie the increased familiality. If the
phenotypic correlation between non-MZ pairs is more than half the phenotypic
correlation between monozygotic twin pairs, a common environmental effect on
the trait is indicated. If the phenotypic correlation between non-MZ pairs is
less than half the phenotypic correlation between monozygotic twin pairs, then
this indicates genetic dominance or an epistatic (gene-gene interaction) effect
on the trait. When variance components were being estimated the phenotypic
mean and phenotypic variance of the whole sample was used (i.e. separate
means and variance were not estimated for siblings, MZ twins and DZ twins).
Furthermore, it was assumed that the MZ-DZ, MZ-sibling, DZ-DZ, DZ-sibling
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and sibling-sibling covariances were equal, and a single correlation was estimated
for these non-MZ pairs.
The twin analysis method described above relies on the assumption that the only
difference between MZ and non-MZ pairs is the degree of genetic relationship
between the individuals. However, the common environmental influence on MZ
and non-MZ pairs could also be different. For example, the fact that MZ twin
pairs look more alike could lead to them being treated more similarly. More effort
may be made to keep MZ twins together throughout their schooling, or parents
may have a greater tendency to dress them alike. The classic twin analysis
does not account for a greater common environmental component in MZ twins
compared to non-MZ pairs. However, results from other methods (for example,
extended family studies such as that carried out by Towne et al. (2005) for
age at menarche) have been in general agreement with the findings of twin studies.
The means and variances of the monozygotic twins, dizygotic twins and siblings
were calculated. The covariance and correlation was calculated for monozygotic
twin pairs, dizygotic twin pairs, sibling pairs and non-MZ pairs using MX (Neale
et al., 2002).
‘Non-survival analysis’ method: Here, the analysis is carried out assuming
age at menarche is normally distributed and that censoring can be ignored.
The amount of phenotypic variance explained by additive genetic (A), common
environmental (C), specific environmental (E) and dominance/epistatic effects
(D) was estimated through structural equation modelling, using the software
package MX (Neale et al., 2002). The additive genetic matrix is equivalent to
the relationship matrix previously described. The common environment matrix
is unity for pairs of individuals from the same family and zero otherwise. The
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specific environmental matrix is zero for all pairs of individuals and unity for each
individual with itself. The dominance/epistatic matrix is 0.25 for sibling pairs,
unity for MZ twins and zero otherwise. Censored observations were included in
the analysis by giving the age at last seen as an age at menarche. The censored
nature of the data was not accounted for in the statistical analysis. To allow a
direct comparison to the survival analysis method, described later, the mean and
variance of age at menarche was equated across all zygosity groups. An ACE
model, or if the non-MZ pair correlation was less than half the MZ correlation,
the ADE model, was fitted to the age at menarche data. More simplified models
were fitted in turn to test whether A, C (or D), or both parameters could be
dropped from the full model. The fit of each sub-model was assessed by the
difference in log likelihood between the sub and full models. Twice the difference
in log likelihood follows a χ2 distribution with the degrees of freedom equal
to the difference in degrees of freedom between the sub and full models. For
variance components, the distribution of likelihood ratio test statistics under
the null hypothesis is a 50:50 mixture of a point mass at zero and a chi-squared
distribution with one degree of freedom (Self and Liang, 1987; Stram and
Lee, 1994). A chi-squared goodness of fit test was used to directly compare the
full model to the reduced models. P -values were calculated from a chi-square
distribution with 1 degree of freedom and subsequently divided by a factor of two.
A P -value of less than 0.05 indicates a significant reduction in the fit of the model.
If the ACE model provides the best fit to the data, the heritability is reported
as the proportion of the variance explained by additive genetic effects. If the
ADE model is the best fitting model then the broad-sense heritability is the sum
of the proportions of variance explained by additive and dominant genetic effects.
Survival analysis method: To investigate the effect of modelling the censored
observations correctly in the biometrical analysis, the general mixed-effects Cox
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model of Ripatti and Palmgren (2000) was used. The analysis was carried out
using the UNIX-based S-PLUS package KINSHIP (Therneau, 2003). The package
was ported into the R environment (R Development Core Team, 2005) for ease
of use and free availability. Censored observations were again included in the
analysis by inputting the age at last seen as an age at menarche. A status vector
was included to distinguish between censored and fully observed age at menarche
data, where 0 indicated a censored observation and 1 indicated a fully observed
age at menarche. The makekinship function within the KINSHIP package creates






where A is the relationship or kinship matrix, L and N are the relationships
of individuals 1 and 2 with themselves (which are always 0.5), and M is the
relationship of individual 1 to individual 2 (which for siblings is 0.25). M ′ is
identical to M and contains a pointer to the A12 element of the matrix. Dummy
parents were created and included to establish the familial relationships.
The makekinship function does not account for identical twins so the relationship
matrix was manipulated manually to give the correct genetic relationship. If, in a
family of three siblings, siblings 1 and 2 are identical twins then the corresponding















where the matrix element A12 has been multiplied by a factor of two to account
for the identical twins. So the relationship matrix remained positive definite,
a small constant (0.001) was added to the diagonal of the full matrix. The A
matrix fitted using MX is twice the relationship matrix fitted using COXME. A
common-environment matrix (C) was created by changing all non-zero elements
of the relationship matrix to 1. A small constant (0.0001) was again added to the
diagonal of matrix to make the matrix positive definite. A matrix which models
dominance effects was also created, where the diagonal of the matrix was fixed to
1.001, MZ pairs had a covariance of 1 and non-MZ pairs had a covariance of 0.25.
The variance explained by non-shared environmental effects cannot be estimated
by COXME because the error term is not in the linear predictor section of the
model. The AC model, or, if the DZ correlation was less than half the MZ
correlation, the AD model, was fitted to the age at menarche data. Simplified
models, A only and C/D only, were then fitted in turn to test if the A or C/D
parameters could be dropped from the full model. The fit of each sub-model was
evaluated using the difference in integrated likelihoods between the sub and full
models. The difference in integrated likelihoods follows a chi-square distribution
with degrees of freedom equal to the difference in degrees of freedom between
the models. The chi-squared statistic was subsequently divided by a factor of
two to ensure the correct distributional properties. A P -value of less than 0.05
indicated a significant reduction in the fit of the model.
The interpretation of the variance (θ) from COXME is not straightforward.
As COXME fits a semi-parametric Cox model to the data, a one-to-one
transformation of the age at menarche data does not change the variance
explained by the model parameters. Thus, a transformation of the time scale
to make the hazard constant will not affect the variance component estimates
or the likelihoods of the fitted models. A constant hazard indicates that the
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survival times are distributed exponentially. The exponential distribution is a
special case of a Weibull distribution. Therefore, the method first put forward
by Yazdi et al. (2002) for interpreting the variance from a parametric Weibull
proportional hazards threshold model can be used. del P. Schneider et al. (2005)
extended the method to take into account multiple random effects and to make
better use of the proportion of censored observations. Using the method of del
P. Schneider et al. (2005), the heritability (h2) of age at menarche from an ACE









where σ2a is the variance explained by the additive genetic effects (the relationship
matrix), σ2c is the variance explained by the common environment, and Pc is the
proportion of censored observations. With this interpretation, the proportion
of variance explained by non-shared environmental effects is quantified by 1
1−Pc
(the error term). Replacing σ2c with σ
2
d allows one to quantify the proportion of
variance in an ADE model explained by dominance (or epistatic) effects.
With the survival analysis method, the covariance between the random (frailty)
effects (e.g., A and C/D) are defined in the model for the hazard. That is,
(co)variances act linearly on the log-hazard scale. The random effects allow the
hazards of individuals to be proportional to each other. A covariance of the
random effects implies that the hazards of a pair of individuals are correlated.
Since there is a non-linear relationship between time-to-event data and the hazard
function, the relationship between covariances on the (log)hazard scale and on the
time-to-event scale will also be non-linear. A large covariance on the log-hazard
scale implies more correlated time-to-event observations.
86
Figure 4.3.1: Age at menarche reported at age 12 versus age at menarche
reported at age 14. From the sample of 1,302 individuals, 140 individuals
reported an age at menarche at both age 12 and age 14.
4.3 Results
Of the total 1,302 females with age at menarche data, 140 individuals reported
an age at menarche at both age 12 and age 14. The correlation between the age
12 and age 14 estimates was 0.81 (Figure 4.3.1). Summary statistics, including
means and variances, are given for the MZ twins, DZ twins and siblings in Table
4.3.1. The within-pair correlations for MZ/MZ, DZ/DZ, sibling/sibling and
twin/sibling pairs are given in Table 4.3.2. The MZ correlation is significantly
greater than both the DZ and sibling correlation, suggesting a genetic effect on
age at menarche.
The mean age at menarche within the total sample is 154.9 months, and the
variance is 174.3. The sibling variance is not significantly different to that of
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Table 4.3.1: Statistical descriptions of the AAM data for the MZ twins, DZ
twins and their non-twin sisters
MZ twins DZ twins Non-twin sisters
Number of individuals 446 633 223
Mean (months) 154.6 154.3 156.6
Variance 175.2 169.1 183.1
Number of censored individuals 62 108 14
Proportion of censored individuals 0.139 0.171 0.063
The DZ sample contains both female-female DZ pairs and female twins from
opposite sex twin pairs. Only individuals with an age at last interview of 12
years or more are included.
the MZ or DZ twins. There is a large, though not significant, difference in
the correlations between DZ and sibling pairs. The siblings have a much lower
correlation than the DZ twins. This is perhaps not unexpected given that the
sibling-sibling correlation is calculated using only 21 sister pairs. Assuming a
single mean and variance for all zygosity classes, the non-MZ pair correlation for
age at menarche is 0.44 (95% CI = 0.35-0.52). Under the above assumptions, the
MZ pair, DZ pair and sibling pair correlations are 0.82 (95% CI = 0.78-0.85), 0.57
(95% CI = 0.46-0.66) and 0.23 (95% CI = 0.00-0.55), respectively. The non-MZ
correlation is more than half the MZ correlation, therefore suggesting that an
ACE model is the correct model to fit to the data.
4.3.1 ‘Non-survival analysis’ method
The results of the non-survival biometric analysis, carried out using MX, are
given in Table 4.3.3. The best fitting model is an AE model. The heritability
(h2) of age at menarche within the current adolescent sample, calculated using
MX, is 0.82 (95% CI = 0.78-0.85).
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Table 4.3.2: Pairwise statistics for the age at menarche data in MZ pairs, DZ
pairs, sibling pairs and twin/non-twin pairs.
MZ/MZ DZ/DZ Sib/Sib Twin/Sib
pairs pairs pairs pairs
Number of pairs 223 164 21 226
Correlation (r2) 0.82 0.57 0.23 0.35
r2 95% confidence interval 0.78-0.85 0.46-0.66 0.00-0.55 0.21-0.46
All correlations and confidence intervals were calculated using MX (assuming one
mean and one variance across all zygosity groups). Only individuals with an age
at last interview of 12 years or more were included.
4.3.2 Survival analysis method
The results of the biometrical analysis carried out using COXME are given in
Table 4.3.4. As suggested by the MZ and DZ twin pair correlations, the best
fitting model is an ACE model. The approximation of the heritability (h2) of age
at menarche within the current adolescent sample, calculated using COXME, is
0.57. COXME does not currently allow the calculation of confidence intervals.
4.4 Discussion
In the present study, if the age at menarche for an individual is censored, the age
at last seen is used in the analysis. This method is perhaps the simplest method
to adopt, and if the censored nature of the observations is accounted for in the
statistical model it introduces no bias to the results. However, if the censored
observations are not taken into account when analysing the data, as with the
MX analysis carried out here, there is a potential for bias to be introduced in
the estimation of the variance components. The different ascertainment of the
twins and the siblings leads to a greater proportion of the siblings being censored




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the total twin sample). Furthermore, the mean age at last seen differs between
the two groups (138.20 months for siblings and 151.48 months for twins). As
the proportion of censoring in the sample increases so does the bias introduced
by failing to account for the censoring in the statistical model. The difference
between the censored siblings and censored twins with regard to mean age at
last seen is also likely to increase the bias. After the removal of the siblings with
an age at last seen less than 12 years old, the percentage of censored siblings
dropped to 6.28%, with the mean age at last seen within the censored siblings
increasing to 169.36 months. There remains a large difference (17.88 months)
between the mean age at last seen of the siblings and twins, and this difference is
due to the different ascertainment of the two groups. However, after the removal
of siblings less than 12 years old, the total proportion of censoring is much
smaller. Hence, the amount of bias introduced to the analysis when using a non-
survival analysis method is expected to be significantly reduced by this treatment.
Further analyses were carried out to investigate the different ascertainment
of siblings and twins, and its effects on the variance components estimates.
The initial analysis, described above, selected only those twins with an age at
interview of 12 years or more. A second analysis was carried out as described
previously, but all siblings were removed from the sample prior to the estimation
of variance components. A third analysis, which included all siblings regardless
of age last seen, was carried out using the same methods. A summary of the
results from all three analyses is given in Table 4.4.1.
When using COXME the siblings have little influence on the estimation of the
variance components and the best fitting model, regardless of the inclusion
criteria placed on the sibling sample, is an ACE model. This indicates that the
























































































































































































































































































































































































































































twins. However, the non-survival analysis method, carried out using MX, is
not robust to the inclusion criteria placed on the sibling sample. If all siblings
are included in the analysis the best fitting MX model is an ADE model; if all
siblings are excluded from the analysis the best fitting MX model is an ACE
model. The inclusion of the siblings clearly has a large effect on the variance
component estimates when using a non-survival method. The only difference
between the survival and non-survival methods is that the survival method
correctly models the censored nature of the data in the statistical model, whereas
the non-survival analysis does not. If all siblings are removed from the sample,
there is agreement between the MX and COXME analyses, both with regard
to the best fitting model (ACE) and the proportions of variance explained by
these components. This suggests that the non-survival analysis is sensitive to
the inclusion criteria of the siblings because of the different ascertainment and
censoring seen in the siblings in comparison to the twins.
It was previously hypothesized that the bias introduced to the non-survival
analysis estimation of variance components could be reduced by the selection
of siblings with an age at last seen of 12 years or more. The results shown in
Table 4.3.2 prove this hypothesis to be correct. Given that an ACE model is
consistently the best fitting model when using a survival analysis method to
estimate the variance components underlying variation in age at menarche, it
is assumed that this is the best model to describe the variance in the current
data. If the siblings with an age at interview of less than 12 years old are
removed from the sibling sample, the non-survival analysis variance component
estimates become closer to those estimated using the survival analysis method.
The siblings are still introducing a small bias in the non-survival analysis, and
this is only completely removed when the sibling sample is removed altogether.
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The correlations (r2) presented in Table 4.4.1 show the concordance in reported
age at menarche to be greater in DZ pairs than in twin-sib pairs. This suggests
a twin specific environmental effect on variance in reported age at menarche.
However, because the correlations were estimated using MX, the censored nature
of the data was not taken into consideration. Therefore, the different correlations
reported for the DZ pairs and nontwin pairs could be due to the different censoring
properties of the two groups. To investigate this further, a twin effect matrix was
fitted using COXME (which accounts for the censoring present in the sample).
If a significant difference exists between the correlations of the DZ pairs and
non-twin pairs, the ACT model (additive genetic, common environment and twin
specific variance components) will give a significantly better fit than the model
where the twin specific environment effect has been dropped. The results of
this investigation suggested that the twin specific environmental effect could be
dropped from the model without significantly reducing the fit of the model (P
= 0.73). It is therefore concluded that the difference in correlation between the
DZ pairs and non-twin pairs shown in Table 3 are an artifact of the censoring
properties of these two groups. The assumption that the means, variances and
co-variance can be equated across zygosity groups appears to be correct.
Towne et al. (2005) review previous twin studies of age at menarche data and
conclude that the heritability of age at menarche is approximately 0.50. This
study provides evidence to support the findings of Towne et al. (2005). The
components underlying variation in age at menarche are much more unclear. Of
the 7 biometric studies discussed in Section 4.1, three different models (ADE,
ACE, and AE) are given to describe variation in age at menarche. The present
study suggests that the variation in age at menarche is influenced chiefly by
additive genetic effects, with approximately 25% of the variance due to common
environmental effects.
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In summary, a biometric genetic analysis has been carried out on a sample of
adolescent twins and siblings. The heritability of age at menarche was estimated
to be 0.57 using a mixed effects Cox model. The analysis was carried out
using a correlated frailty model to account for the 16.65% of individuals with a
censored age at menarche. The analysis was also carried out without statistically
accounting for the censored observations in the model, and when all siblings
were removed from the analysis a heritability of 0.50 was reported. The best
fitting model under both methods of analysis separated the variance in age at




A genome-wide linkage scan for loci
influencing variation in age at
menarche
5.1 Introduction
As discussed in the previous chapter, age at menarche is a complex trait which
is influenced by both genetic and environmental factors. The onset of menses
is an important event both biologically and socially and the age at onset has
been identified as a risk factor for several traits. Early age at menarche is a
significant risk factor for several conditions, including depression (Kaltiala-Heino
et al., 2003), eating disorders (Kaltiala-Heino et al., 2001), breast cancer (Velie
et al., 2006) and endometriosis (Missmer et al., 2004). Late age at menarche has
been associated with osteoporotic fractures (Naves et al., 2005) and a reduced
risk of coronary heart disease (Cooper et al., 1999). The identification of QTL
contributing to variation in age at menarche could potentially lead to a better
understanding of factors underlying this wide range of phenotypes.
A secular decrease in age at menarche has occurred in developed countries over
the past century (Ong et al., 2006). This decrease is believed to be associated
with the improved nutritional status, greater amounts of adipose tissue and
the improved general health of adolescent females, though substances with
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oestrogen-like actions that are present in nutrients have also been reported
to play a role (deMuinich Keizer-Schrama and Mul, 2001). However, data
from the Fels Longitudinal Study suggests that the population shifts in age at
menarche and BMI are largely independent (Demerath et al., 2004). This lack
of association between BMI and age at menarche could be because BMI is an
imprecise indicator of adiposity, particularly in children. It has been reported
that the timing of menarche is more closely linked with body composition (i.e.
body fat, fat percentage and lean tissue mass) during periods of growth and
development. The Fels Longitudinal Study did find a correlation between adult
BMI and reported age at menarche (Demerath et al., 2004). There is evidence of
a significant socioeconomic effect on age at menarche with means of 13.2 and 14.6
reported in privileged versus underprivileged black South African populations
(Hughes and Kumanan, 2006). It is possible that the socioeconomic effect is due
to an underlying nutritional effect on age at menarche as the two variables are
likely to be highly correlated. A large multi-national study carried out by the
World Health Organisation showed the median age at menarche to be 14 years
though the analysis included many studies from developing countries. A mean
age at menarche of 13 years was reported for the Australian sample (Morabia
et al., 1998).
The biological mechanisms through which puberty is mediated are only partially
understood. Neurological control of the reproductive axis is driven by the
hypothalamus, which has excitatory effects on the pituitary gland, leading to
the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH),
which in turn regulate ovarian activity (Gottsch et al., 2006). The initiation
of menstrual cycles results from a series of developmental and neuroendocrine
events that lead to full activation of the hypothalamic GnRH pulse generator and
initiation of cyclic ovarian function (Tena-Sempere, 2006). Recent research has
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focussed on the fundamental role of the Kisspeptin pathway in neuroendocrine
regulation of the reproductive axis and initiation of puberty (Figure 5.1.1).
Kisspeptin neurons in the anteroventral periventricular (AVPV) and arcuate
(ARC) nuclei of the hypothalamus stimulate GPR54 receptors on GnRH neurons
(Messager et al., 2005).
A range of factors is involved in the control of puberty onset via the GnRH
pulse generator, including leptin. Leptin is thought to provide information
regarding the nutritional status of an individual to the hypothalamus and
pituitary gland. Leptin, which is released from adipose tissue, has a stimulatory
effect on both the ARC nucleus and the pituitary gland, leading to an increase
in KISS neuron activation and circulating levels of LH and FSH, respectively
(Yu et al., 1997; Caprio et al., 2001). Leptin could be underlying the correlation
between body mass index and age at menarche.
To date, only two genome-wide linkage scans for genes underlying variation in age
at menarche have been performed (Guo et al., 2006a; Rothenbuhler et al., 2006).
Using 98 sister pairs Rothenbuhler et al. (2006) found three suggestive linkage
peaks on chromosomes 16q21, 16q12 and 8p12 for weight-adjusted age at
menarche. Three further suggestive QTL were identified on chromosomes 22q13,
22q11 and 11q23 following a linkage analysis for age at menarche carried out
on a sample of 1,946 sister pairs (Guo et al., 2006a). No replicated linkages
have been reported for age at menarche and this is most likely due to a lack of
powerful study designs; a study with a sample size of only 98 randomly selected
sister-pairs will not have enough power to map loci underlying a complex trait
such as age at menarche.



















Figure 5.1.1: The neuroendocrine reproductive axis. Kisspeptin neurons
in the anteroventral periventricular (AVPV) and arcuate (ARC) nuclei of
the hypothalamus stimulate GPR54 receptors which stimulate gonadotropin-
releasing hormone (GnRH) to be released from GnRH neurons. GnRH acts
on the pituitary gland and initiates the release of follicle-stimulating hormone
(FSH) and luteinizing hormone (LH). These hormones stimulate the gonads,
which leads to an increase in the production of estrogen and testosterone,
initiating puberty. The system is controlled via positive and negative feedback
loops which act on the hypothalamus. Adipose tissue releases leptin which has
a stimulatory effect on the ARC and pituitary gland and helps drive puberty.
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estrogen receptor a (ESR1) gene (Stavrou et al., 2002), the estrogen-biosynthesis
gene CYP19 (Guo et al., 2006b), and the sex hormone-binding globulin (SHBG)
gene (Xita et al., 2005). A recent review of CYP17 gene polymorphisms reported
that 7 out of 11 studies suggested a modest association between CYP17 genotype
and age at menarche (Sharp et al., 2004).
In the present study, age at menarche data from four large-scale Australian
study cohorts are combined to create the largest phenotypic sample of age at
menarche to date. The aim is to conduct a highly-powered linkage analysis for
loci underlying normal variation in age at menarche.
5.2 Methods
5.2.1 Phenotypic Sample
Age at menarche data were drawn from a cohort of adolescent twin families,
from two cohorts of adult twin families and from a cohort of affected sister-pair
families recruited for a linkage study of endometriosis.
Adolescent twin families: The adolescent twins and their families are
decribed at length in the previous chapter. Of the 1,351 adolescent individuals
in the sample, 226 (16.73%) had a censored age at menarche (i.e. the true age at
menarche was unknown as the individual had not started puberty at the time of
last interview). If censored observations are omitted from a sample then a bias is
introduced when calculating means and variances and estimating heritabilities.
In an attempt to reduce this bias the age at last seen was taken as the age at
menarche.
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Adult twin families: From 1980 to 1982, age at menarche information was
collected from both members of 1,888 MZ and DZ female twin pairs as part
of a health survey mailed to twins on the Australian Twin Registry. The
cohort comprised of twins born between 1913 and 1964. Females were asked
the question ‘How old were you when you had your FIRST menstrual period?’
(years and months) via questionnaire. A biometric analysis of age at menarche
has previously been carried out on the sample (Treloar and Martin, 1990).
From November 1989 onwards the first degree relatives of this twin cohort were
also surveyed and asked the same age at menarche question. Age at menarche
data from this cohort of female relatives are included in the present analysis.
A second cohort of adult twins was recruited in 1989 through the Australian
Twin Registry. The twins were born between 1964 and 1971, and hence were
aged 18 to 24 years when they were initially surveyed by mailed questionnaire.
Immediate family members were also asked to participate. As part of the
questionnaire, participants were asked the question ‘How old were you when you
had your FIRST menstrual period?’ (years and months). Non-responders from
the second cohort were followed up, via interview, between 1996 and 2000 as
part of a study into alcoholism and psychiatric morbidity (Heath et al., 2001).
Participants were again asked to provide an age at menarche. In total, the
adult twin-families provided 6,150 families and 14,175 individuals with age at
menarche information.
Endometriosis families: Age at menarche information was also obtained
from women diagnosed with Endometriosis ascertained from the Australian
component of the International Endogene Study (Treloar et al., 2002). From
1995 to 2002, the Australian group recruited 931 families each with at least
two affected members (mostly affected sister pairs) with surgically diagnosed
endometriosis for a genome-wide linkage scan (Treloar et al., 2005). Included
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in the sample were case-parent trios and some cases without parents (Treloar
et al., 2002). All affected female family members were asked the question
‘How old were you when your periods began’ (whole years) via questionnaire.
The total Australian sample provided 4,274 individuals with age at menarche
information.
Given the small proportion of censored observations in the total phenotypic
sample (1.20%) and the use of the age at last seen as an age at menarche in
these cases, the bias in the present study as a result of censoring is predicted
to be very small. For all study cohorts, where two or more age at menarche
estimates were available for an individual, the estimate provided at the first
data collection following menarche was used. It was assumed that the recall
closest in time to menarche would be the most accurate. Age at menarche
estimates less than 104 months (10 individuals) and greater than 208 months
(64 individuals) were classified as outliers and removed from the analysis. These
cut-offs approximately represented three standard deviations above and below the
mean. The total phenotypic sample for the present linkage analysis comprises of
19,782 individuals with an age at menarche. Phenotypic bivariate outliers were
identified and removed to ensure that linkage signals were not overly influenced
by extremely discordant sib-pairs. A bivariate outlier is defined as a sib-pair with
extreme differences in age at menarche. The distribution of the squared difference




where r is the sib-correlation and σ is the standard deviation, of the trait (age at
menarche). It follows from this that the mean of D2 is given by
E(D2) = 2(1− r)σ2, (5.2.2)
103
and the variance of D2 is given by
σ2(D2) = 8(1− r)2σ4. (5.2.3)
Hence, the expected standard deviation of the squared difference is
σ(D2) = 2
√
2× (1− r)σ2. (5.2.4)
Pseudo-independent sib-pairs with a D2 greater than 4σ(D2) + E(D2) were
identified as bivariate outliers. The sib-pair correlation for age at menarche
calculated by SIB-PAIR (Duffy, 2002) was 0.28. The standard deviation of age at
menarche from the full phenotypic sample was 17.20 months (1.43 years). Using
equation 5.2.4 the expected standard deviation of the squared difference between
pseudo-independent sib-pairs was 602.47 months2. Using equation 5.2.2 the
mean of D2 equals 426.01 months2. Therefore, any pseudo-independent sib-pair
with a squared difference in age at menarche of more than 2835.88 months2
was identified as a bivariate outlier. This is equivalent to an actual difference
of
√
2836/12 = 4.44 years between the age at menarche of pseudo-independent
sib-pairs. For each pseudo-independent sib-pair identified as a bivariate outlier
the age at menarche which differed most from the sample mean was removed
from further analysis.
5.2.2 Genotypic Sample
Adolescent twin families: Three genome-wide scans using microsatellite
markers were carried out on extracted DNA from blood samples collected
from the adolescent melanoma and cognitive ability families. Details of the
genotyping and genetic data cleaning procedures have been described previously
(Zhu et al., 2004). Genetic data from all three genome screens are used in the
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present study. The adolescent samples provided 628 individuals with both age
at menarche and genotypic data to this present analysis.
Adult twin families: Four microsatellite genome-wide scans have been
completed on DNA extracted from blood or buccal samples collected from
individuals within the two adult cohorts. The genotyping and genetic data
cleaning procedures for all four scans have been described, at length, previously
(Cornes et al., 2005). The adult cohorts provided 3,544 individuals with both
phenotypic and genotypic data to the present study.
Endometriosis families: Details of the genotyping and genetic data cleaning
procedures for the endometriosis cohort have been detailed elsewhere (Treloar
et al., 2005). A single 400 marker genome-wide screen was carried out on the
Australian families. In a time and money saving exercise, the final batch of 79
families was genotyped using only 113 markers across chromosomes 9, 10, 11, 19,
20, 21, 22 and X. The endometriosis cohort provides 2,160 individuals with both
phenotypic and genotypic data to the present study.
In total, the present study comprises 6,332 individuals and 2,685 pseudo-
independent sib-pairs with age at menarche and genotype data. This is the
largest sample of pseudo-independent sib-pairs used to date in a genome-wide
scan for loci influencing age at menarche. Of the 2,685 pseudo-independent
sib-pairs in the linkage sample 42 were identified as bivariate outliers (i.e. had
a difference in age at menarche of more than 4.44 years). After the removal of
bivariate outliers the linkage sample consisted of 6,290 individuals and 2,631
pseudo-independent sib-pairs.
In addition to the initial checks of genetic data which were carried out during
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the original studies, further checks were applied following the amalgamation
of cohorts. The data were re-checked for Mendelian errors using SIB-PAIR
(Duffy, 2002). Unlikely genotypes were identified and wiped using MERLIN
(Abecasis et al., 2002).
This study uses an updated version of a previously described (Nyholt et al., 2005)
genetic map which takes physical map positions from NCBI build 35.1 and
genetic map positions from published deCODE and Marshfield data (Kong
et al., 2002; Myers et al., 2005; Duffy, 2006). Where the same marker was typed
in several genome-screens, the multiple marker versions were offset by 0.002cM
to prevent them sharing the same map position and to negate the need to re-bin
alleles across all studies.
5.2.3 Statistical analysis
The mean and variance of age at menarche was calculated both within and across
all studies. Genome-wide variance-component (VC) linkage analysis was carried
out using MERLIN (Abecasis et al., 2002). VC linkage analysis is a model-
free analysis method, i.e. penetrance parameters and disease gene frequencies
are unspecified. Identity-by-descent (IBD) coefficients were calculated at 1cM
intervals. The IBD coefficient gives the number of alleles two individuals share,
at a given locus, which are derived from the same ancestor (0, 1 or 2 alleles).
Variance-component models are based on the correlation between the genetic
similarity of relatives at a given locus (estimated IBD coefficients) and the
relatives’ similarity with respect to the phenotype (age at menarche). Phenotypic
data were assumed to follow a multivariate-normal distribution. MERLIN allows
the inclusion of phenotypic information from both members of a monozygotic twin
pair provided the individuals are input as a monzygotic twin pair. In the present
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linkage scan, age at menarche data from monozygotic twins was included, which
increases the power to detect linkage (Evans and Medland, 2003). In accordance
with previously proposed significance levels (Lander and Kruglyak, 1995) for
model-free genome-wide linkage analysis, a genome-wide significance threshold
of LOD = 3.3 was adopted. Suggestive evidence of linkage was reported when a
LOD score greater than or equal to 1.9 was observed. The linkage analysis was
carried out both before and after the removal of bivariate outliers. It is worth
highlighting that the full pedigree structure is fitted in the variance component
model and that the dependency between pseudo-independent sib-pairs is therefore
fully accounted for. The term ’pseudo-independent pair’ is only used to give an
approximate estimate of power and to identify within-family bivariate outliers.
5.3 Results
The mean and variance of age at menarche within and across studies is shown in
Table 5.3.1. After combining phenotypic data from all four studies the mean and
standard deviation of age at menarche was 13 years and 1.42 years, respectively.
Figure 5.3.1 shows the distribution of age at menarche estimates following the
removal of outliers. The means and variances reported here are similar to those
reported in previous studies (Towne et al., 2005). Variance-component analysis
showed the heritability of age at menarche within our study to be 64% (where
all familial resemblance is assumed to be additive genetic), which is similar to
levels of heritability reported in other studies (Towne et al., 2005; Treloar and
Martin, 1990).
Results of the genome-wide variance-component linkage analysis are shown in
Figure 5.3.2 along with the locations of candidate genes. Two primary candidate
genes, INS and GPR54 are included even though they are located at the extreme
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Figure 5.3.1: Histogram of age at menarche data from 19,782 Australian females
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Table 5.3.1: Means and standard deviations of age at menarche from four
different Australian cohorts
Study Individuals Mean Standard deviation
(months) (months)
Adolescents 1345 154 14
Adults 1 (1980 cohort) 9099 157 17
Adults 2 (1989 cohort) 5076 158 17
Endometriosis 4262 154 18
Combined 19782 157 17
Linkage subset 6332 156 17
ends of chromosomes 11 and 19, respectively, and are outside the resolution of
the current genome-wide scan. If either gene had a major effect on the trait
one would still expect to see a LOD peak at the start of our marker region on
chromosome 11 or 19, and this is not the case. Whilst this does not rule out
INS or GPR54 as genes with effects on age at menarche, it is unlikely they have
a large effect in the current population. Regions of suggestive linkage (LOD =
1.9) were found on chromosomes 3 and 11, with LOD scores of 2.31 and 2.16,
respectively. The linkage peak on chromosome 3 was found at a map position of
10.2cM, located on the p-arm of the chromosome between markers D3S1297 and
D3S1620. The linkage peak on chromosome 11p was located at a map position
of 56.9cM, between markers D11S4200 and D11S1900. Both of these suggestive
linkage regions are novel loci for genes influencing age at menarche. A summary
of the five most significant loci identified by genome-wide linkage analysis is
provided in Table 5.3.2.
The LOD score profile across the chromosomes changed significantly after the
removal of bivariate outliers. The LOD score peaks on chromosomes 3 and 11
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Table 5.3.2: Summary of the five most significant loci from multipoint variance-
component linkage analysis for age at menarche
Chromosomal Location LOD score Flanking markers
Band Upstream Downstream
3p26 10 2.31 D3S1297 D3S1620
11p13 57 2.16 D11S4200 D11S1900
12q24 133 1.77 D12S79 D12S86
9q21 84 1.18 D9S167 D9S257
12q21 96 1.13 D12S106 D12S379
decreased from 2.31 and 2.16 to 0.49 and 1.11, respectively, and are no longer
of suggestive significance. This indicates that the removed pseudo-independent
sib-pairs provided a large proportion of the information for linkage at these loci.
Perhaps more encouraging is the LOD score peak seen on chromosome 12 which
did not change after the removal of the bivariate outliers. This suggests that the
removed individuals had little influence on the LOD score at this test locus. In
addition, a larger peak with a LOD score of 1.88 is seen on chromosome 12 at a
position of 154cM, which suggests the bivariate outliers had a negative effect on
the LOD score profile in this genomic region. Other chromosomes with increased
lod score peaks include chromsomes 8, 17 and 22, which after the removal of
bivariate outliers show LOD score peaks of 1.27, 1.75 and 1.52, respectively.
5.4 Discussion
In this study, a genome-wide scan for loci influencing age at menarche was
conducted using a sample of 6,332 Australian females. Multipoint variance-
component linkage analyses revealed suggestive linkage on chromosome 3p26































































A search for candidate genes was carried out within the confidence regions of
the linkage peaks on chromosomes 3 and 11 (see Figure 5.3.2). The confidence
region of a QTL is defined as the region of the chromosome with a LOD score
= peakLOD - 1. No candidate genes were identified within the QTL confidence
region on chromosome 3. The confidence region on 11p harbors two excellent
candidate genes for age at menarche. Wilms Tumour 1 (WT1 [OMIM: 607102])
is a 48,000 base-pair gene located on chromosome 11p13. WT1 is required
for the normal formation of the genitourinary system and mesothelial tissues.
WT1 is expressed in immature follicles and has been associated with follicular
development. In WT1 knockout mice gonadal development is inhibited, which
indicates that WT1 is necessary for the differentiation of the gonadal ridge
(Kreidberg et al., 1993). Individuals with Wilm’s Tumour, or the related Frasier
syndrome and Denys-Drash syndrome, are often infertile. The role of WT1
in follicular development and the syndromes associated with WT1 mutations
suggest that WT1 is a prime candidate for a gene influencing age at menarche.
The second candidate gene within the chromosome 11p linkage region is
Follicle stimulating hormone - beta polypeptide (FSHB [OMIN: 136530]),
a 2,278 base pair gene located on chromosome 11p13. FSH drives ovarian
folliculogenesis to the antral follicle stage, and individuals with no FSH-receptor
activity have been shown to have hypergonadotrophic primary amenorrhea
and hyperplastic ovaries (Huhtaniemi, 2002). FSH plays a critical role in the
neuroendocrine axis and induces estrogen to be released from the ovaries (see
Figure 5.1.1). Concentrations of FSH are known to increase during normal
pubertal development. Several studies have reported mutations within FSH as
the causal variants for amenorrhea. A two base pair frameshift deletion was
found in the coding sequence of the FSH gene from two women, one Italian
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and one Israeli, with primary amenorrhea and infertility associated with an
isolated deficiency of pituitary FSH (Matthews et al., 1993; Matthews and
Chatterjee, 1997). A 16 year old female with amenorrhea who had undergone
pubarche (pubic hair development) but not thelarche (breast development)
was shown to be heterozygous for two FSH mutations. Each of the mutations
prevents the normal combination of the alpha and beta subunits to form intact
FSH. The authors conclude that the findings indicate that FSH is required for
follicular development and ovarian androgen and estrogen synthesis in females
(Layman et al., 1997). These findings together suggest that the FSH gene is an
excellent candidate for a gene with influence on age at menarche.
After the removal of bivariate outliers the LOD score profile changed substantially.
This is not unexpected as extremely discordant sib-pairs are very informative for
linkage. For a chromosomal region where an extremely discordant sib-pair share
zero or two alleles identical-by-descent that sib-pair will have a large influence
on the LOD score. Where they share zero genes identical-by-descent the sib-pair
will have the effect of increasing the LOD score and where they share two genes
identical-by-descent they will decrease the LOD score. In the perfect scenario
a LOD score peak is influenced by multiple sib-pairs and multiple families, but
this is seldom the case as the extremely concordant and discordant sib-pairs
provide the majority of the power to detect linkage. For this reason, it is difficult
to know how to correctly handle bivariate outliers in linkage analysis, hence
why the analysis is carried out both with them included and excluded. It seems
reasonable to suggest that one may have more confidence in a linkage peak that
is still present in the absence of bivariate outliers (chromosome 12), than those
that are seen only in their presence (chromosomes 3 and 11). Furthermore, the
aim of this study was to identify loci underlying the normal variation in age at
menarche, and therefore it would seem wise to pay particular attention to the
113
linkage results following the removal of bivariate outliers.
The factors leading to bivariate outliers remain unclear, but one possible
explanation is that the age at menarche for one individual within the pseudo-
independent sib-pair is incorrect. This could, in part, be due to recall or
measurement error on behalf of one or both members of the twin pair. The
removal of bivariate outliers could therefore be removing the most extreme
incidents of recall bias. Another, and perhaps more interesting, explanation is
that the individual within the pair with the most extreme age at menarche is
segregating a polymorphism of major effect upon the trait. The timing and
control of puberty is believed to be driven by the hypothalamus and so primary
candidate genes are thought to act at this level of the pubertal axis. The linkage
peak around FSHB decreases after the removal of bivariate outliers, and it is
known that FSHB acts at the level of the ovary, not the hypothalamus. Genes
with effects on the ovaries are not expected to have control over the normal
regulation of pubertal timing, but they could have an effect on the ability of a
female to ovulate. This is supported by the studies that reported amenorrhea
in women with mutations in FSHB (Matthews et al., 1993; Matthews and
Chatterjee, 1997; Layman et al., 1997). An explanation of the decrease seen
on chromosome 11 is that the individuals removed as bivariate outliers are all
segregating polymorphisms within the FSHB gene that have a major effect on a
womens ability to ovulate, and therefore have a major effect on age at menarche.
The polymorphisms are not involved in the pathways that control the timing of
menarche per se.
Despite the large number of sib-pairs the present study reveals no genome-wide
significant linkage peaks, suggesting that the genetic architecture of age at
menarche is complex. If a single QTL explained the variation in age at menarche
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then we would expect to detect a gene of this effect size in a study of this
magnitude. The fact that we have not detected a significant LOD score suggests
that multiple loci are involved in the heritability of age at menarche. This finding
alone is rather unremarkable; however we would still have 93% or 67% power to
detect a QTL (at α = 0.0001, genome-wide significance) that explains 25% or
20% of the trait variation, respectively (Sham et al., 2000; Purcell et al., 2003).
This suggests that age at menarche variation is underpinned by multiple QTL
of small effects and is similar to the genetic architecture of other complex traits
(Reich and Lander, 2001). Large numbers of sib pairs are needed to identify
QTL with small effects using linkage analysis and this would explain why no
statistically significant QTL were detected in the present linkage scan. If a QTL
existed that explained 10% of the trait variation, for a trait with a heritability of
0.65 such as age at menarche, then 13,000 pseudo-independent sib-pairs would
be required to detect the QTL with 80% power. This number of sib-pairs is
outside the scope of most genome-wide linkage studies. The recent availability
of genome-wide association study designs should allow the detection of these
small effect QTL (Sham et al., 2000). Rare alleles with large effects on age at
menarche could still be segregating within the population; however, due to their
rarity, it is unlikely that they will be segregating within our population sample.
Furthermore, due to their rarity they would explain little of the population
variation in the trait.
It has been suggested that including individuals without genome-wide linkage
information in a genome-wide scan for linkage can bias the result towards
the null hypothesis (Schork and Greenwood, 2004), though this claim has
been hotly contested (Abecasis et al., 2004; Cordell, 2004; Mukhopadhyay
et al., 2004; Sieberts et al., 2004; Visscher and Wray, 2004). To look at this
empirically, the genome-wide linkage analysis was repeated using only those
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individuals with genome-wide linkage information. We define an individual as
having genome-wide linkage information if they share 300 or more typed markers
in common with a sibling. Of the 6,332 individuals and 2,685 pseudo-independent
sib-pairs with age at menarche and genotype data, 5,700 individuals and 2,482
pseudo-independent sib-pairs have genome-wide marker data available. There
were no significant differences between the linkage results of the two analyses.
The maximum difference between the LOD scores of the two linkage scans was
0.21, with the higher LOD score resulting from the analysis which included
all individuals, regardless of marker information. This suggests that including
individuals with ‘missing’ inheritance information (i.e. IBD = 0.5) does not bias
the test statistic towards the null hypothesis of no linkage. Furthermore, by
excluding those individuals with less than 300 typed markers shared in common
with a sibling, some linkage information is being lost.
In summary, the largest genome-wide scan for loci influencing variation in age
at menarche has been carried out. Two novel loci of suggestive significance
have been identified on chromosomes 3p and 11p. The linkage region on
chromosome 11 contains WT1 and FSHB, two candidate genes for age at
menarche. Chromosomes 12 and 17 contain loci which just failed to reach
suggestive significance, and these loci were identified in the absence of bivariate
outliers. Given the size of the sample it would appear there are many genes of




Elucidating the genetic basis of phenotypic variation is the foremost goal in the
field of genetics. The much heralded completion of the human genome project
in the year 2001 signalled a new era for ‘gene mappers’ (The International
Human Genome Sequencing Consortium, 2001). Subsequently, many complex
traits have been the subject of gene mapping experiments, particularly those
contributing significantly to the global burden of disease. However, perhaps due
to the complexity involved in the analysis, age at onset data have received much
less attention than standard quantitative traits. The major aim of this thesis
was to identify loci underlying quantitative traits through the use of age at onset
information.
6.1 Thesis summary
Age dependent penetrances were included in a marker-specific parametric linkage
analysis of four families with major depression and comorbid unexplained
swelling (Chapter 2). Parametric linkage analysis was used because, due to the
disease segregation patterns, it was assumed that a Mendelian locus of major
effect was segregating within the families (albeit with incomplete penetrance).
The use of parametric linkage analysis allowed the age-specific penetrances to
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be modelled in unaffected individuals. This approach is perhaps the simplest
way in which the ‘age at onset’ distribution of a trait can be included in a
genome-wide scan for linkage. A locus of suggestive linkage was identified
on chromosome 8q with a LOD score of 2.02. The locus was not identified
in a follow-up non-parametric variance component genome-wide scan, though
a second locus of suggestive linkage was mapped to chromosome 7 (LOD =
2.10). Due to the novel comorbidity phenotype, the sample size was fixed, and
after maximization of marker information a previously suggestive linkage on
chromosome 14 disappeared. Future efforts should be directed at ascertaining
more families with this novel phenotype in an attempt to increase the power to
detect linkage. A more thorough examination of the novel comorbid phenotype
would also aid the hunt for underlying susceptibility loci by increasing the
accuracy of parametric linkage models.
Standard quantitative trait loci (QTL) mapping techniques commonly assume
that the trait is both fully observed and normally distributed. When considering
survival or age-at-onset traits these assumptions are often incorrect. Methods
have been previously developed to map QTL for survival traits; however,
they are both computationally intensive and not available in standard genome
analysis software packages. A grouped linear regression method is proposed
for the analysis of continuous survival data in line crosses (Chapter 3). Using
simulation the method is compared to both the Cox and Weibull proportional
hazards models and a standard linear regression method that ignores censoring.
The grouped linear regression method is of equivalent power to both the Cox
and Weibull proportional hazards methods and is significantly better than the
standard linear regression method when censored observations are present.
The method is also robust to the proportion of censored individuals and the
underlying distribution of the trait. Based on linear regression methodology, the
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grouped linear regression model is computationally simple and fast and can be
readily implemented in freely available statistical software. The extension of the
method to allow the modelling of survival traits in general outbred populations
is an important next step. As previously suggested, a random-effects QTL
model based upon multiple binary indicator variables would naturally fit into
a linear mixed model framework. It is likely that this linear regression based
methodology will produce even greater savings in computation time versus
current methods for mapping survival QTL in outbred populations.
Prior to a gene mapping experiment, a biometric analysis should be carried out
to determine the proportion of variance explained by genetic effects. For age at
onset traits, this usually straightforward step is complicated by the need to use
specialized methods to account for the non-normal distribution of the data and
the censored observations. In Chapter 4, a standard variance component method
was compared to a corresponding survival analysis method using a sample of
1,302 adolescent twins and their siblings for whom age at menarche information
was available. The proportion of censoring in the sample was 16.73%. The
best fitting model following analysis with the survival analysis method was an
ACE model, where 57% and 23% of the phenotypic variance was explained
by additive genetic and environmental effects, respectively. The best fitting
model when using a standard variance decomposition method was an AE model,
where 82% of the phenotypic variance was explained by additive genetic effects.
The phenotypic data were investigated further and the lack of correspondence
between the results of the two methods was found to be an artefact of the
different ascertainment of reports of age at menarche between the siblings and
twins. After the removal of the sibling sample, the correspondence of the two
method increased, with both methods indicating an ACE model was the most
likely. The standard and survival analysis methods estimated the proportion
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variance explained by additive effects to be 0.50 and 0.54, and the proportion
variance explained by environmental effects to be 0.31 and 0.29, respectively.
These results suggest that great care must be taken when using non-survival
analysis methods to decompose the variation in survival traits. Further work is
needed to accurately define the conditions under which survival analysis methods
must be used in place of more traditional schemes.
Only 628 adolescent twins and their siblings had both age at menarche
information and marker data available. For a complex trait such as age at
menarche, where variance is likely to be underpinned by many modest or small
effect QTL, this sample size is too small. In an attempt to increase the power
to detect linkage, the sample was broadened to include adults for whom age at
menarche data was available. The total linkage sample comprised of 2,685 pseudo-
independent sib-pairs with age at menarche and genotype data. This represents
the largest sample of pseudo-independent sib-pairs ever ascertained for a genome-
wide linkage scan for loci underlying variation in age at menarche. Two QTL of
suggestive significance were identified on chromosomes 3 and 11, with LOD scores
of 2.31 and 2.16 respectively. After the removal of bivariate outliers the evidence
for linkage at both of these QTL decreased. However, a third QTL was identified
on chromosome 12 (LOD = 1.88). All of these QTL are novel loci for age at
menarche, though only two previous genome-wide scans for loci influencing age
at menarche have been completed to date. The linkage region on chromosome
11 contains two candidate genes for age at menarche, WT1 and FSHβ. Given
the sample size of the present study and that no significant QTL were identified,
it seems likely that age at menarche is influenced by multiple genes of small to
medium effect. Therefore, a very large number of individuals will be required to
map QTL for age at menarche using a linkage analysis approach. This finding is
in common with those of the majority of complex trait QTL mapping studies.
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6.2 Future directions for gene identification
Five years after the completion of the human genome project and still only a
handful of the polymorphisms underlying complex human traits and diseases
have been unequivocally identified. As discussed in Chapter 1, linkage analysis
has been a lucrative method for identifying loci underlying Mendelian traits,
though much less has been achieved with complex traits. The lack of success is
primarily because the majority of studies not only select heterogeneous samples
but have insufficient power to even detect QTL of modest effect size (Altmuller
et al., 2001). The proportion of significant complex trait linkages that have been
replicated in several independent studies is very small. Even after a linkage
signal has been replicated across several independent studies, the underlying
causal polymorphism is often still difficult to localize because many candidate
genes can reside within the confidence region of the QTL due to the extent of
linkage signals (typically tens of centimorgans for complex traits). Given the lack
of success in identifying polymorphisms underlying complex trait variation using
traditional linkage analysis methods, what does the future hold for gene mappers?
With the mapping of QTL underlying complex traits in mind, several techniques
for improving the efficacy of traditional linkage analyses have been suggested. In
addition, recent advances in technology have presented several new methods for
identifying the underlying causes of complex trait variation.
6.2.1 Improving the design of genetic linkage studies
Inter-study variation in study design, phenotype definition, analysis methods
and selection of genetic markers all reduce the chances of finding a replicated
linkage for a complex trait. When these factors are coupled with interpopulation
heterogeneity and differences in environmental exposures it is perhaps not
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surprising that few complex trait linkage reports have been consistently
replicated across populations.
Phenotype definition is an important issue in complex trait gene mapping.
As discussed previously, locus heterogeneity can be reduced by ascertaining
narrowly defined subsets of disease phenotypes (Chapter 2). The ascertainment
of families with early or late onset, comorbities, multiple affected individuals
or similar disease severities are all classic ways to reduce locus heterogeneity.
However, the assumption that this method will actually increase the number
of replicated linkages is open to debate. As study designs place more and
more selection criteria on linkage samples, the chance of a similar sample being
ascertained in an independent study is surely decreased.
When ascertaining probands for genetic studies, researchers typically depend on
phenotype descriptions from the field of medicine. For example, the definition of
major depression used in Chapter 2 is taken from the Diagnostic and Statistical
Manual of Mental Disorders IV (American Psychiatric Association, 1994), a
manual which serves as a guide to clinicians. While these descriptions are useful
for identifying individuals with a particular ailment, they were never intended
to identify individuals with genetically similar characteristics. A solution to
this problem would be the creation of a set of phenotype specific guidelines for
genetic epidemiologists to follow when ascertaining individuals for a given trait.
Amongst other criteria, the guidelines should give clear definitions of early and
late onset, disease thresholds (e.g. high versus low blood pressure), familial
versus non-familial forms of the disease and any comorbid phenotypes that
should be included. The guidelines would allow independent studies to ascertain
phenotypically similar subsets of disease. This would not only increase the
chances of finding replicated evidence for linkage, but also allow joint analysis
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(meta-analysis) across studies in an attempt to increase power.
The issue of power is a significant problem in complex trait linkage
analysis. Only recently have researchers become aware of the number of
individuals that must be ascertained to identify QTL underlying complex
trait loci. For complex diseases it seems likely that the effect size of any
one polymorphism is likely to be small. The number of pseudo-independent
sib-pairs required to map these loci of small effect using a linkage framework
will run into the tens of thousands (Chapter 5). In an attempt to ascertain
these large number of individuals, several large biobanks have been set
up worldwide, and include Biobank UK (http://www.ukbiobank.ac.uk/),
Generation Scotland (www.generationscotland.org), EPIC Europe
(http://www.iarc.fr/epic/centers/iarc.html), GenomeEUtwin
(http://www.genomeutwin.org), The Western Australian Genome Project
(http://www.genepi.com.au/wagp) and the Decode Genetics Icelandic Biobank
(http://www.decode.com). Biobanks involve the storage of biological and
phenotypic data for large population-based samples. The sample sizes of such
studies are typically in the order of hundreds of thousands, and the largest
population Biobank, the Western Australian Genome Project, includes in excess
of 2 million people. Biobanks which collect family information, such as the The
Western Australian Genome Project, provide an excellent resource for linkage
analysis of complex traits, particularly as the study protocol is consistent for the
entire sample. Population biobanks are an excellent resource for many different
phenotypes, and the data they contain can be put to good use in many different
fields, including human genetics. However, for less common diseases, the size of
the population samples needs to be very large to ensure the ascertainment of
enough affected individuals. How to make best use of this data for the genetic
analysis of complex traits is an ongoing debate, with many authors suggesting
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alternatives to traditional linkage analysis. The number of individuals required
to successfully map a QTL of small effect using linkage analysis rules out the
method in all but the largest of studies, and therefore alternative methods must
be adopted. One such method which has received much attention of late is
genome-wide association mapping.
6.2.2 Genome-wide association studies
The traditional alternative to a linkage study is a hypothesis-driven candidate
gene association study. The advantage of an association study approach is
that a smaller number of individuals is required to detect loci of small effect
(Risch, 2000). As shown in Table 6.2.1, for the detection of small effect
(quantitative trait nucleotide (QTN) explains 1% of the phenotypic variance)
linkage analysis using sib-pairs requires approximately 400 times the number
of individuals needed for an association analysis. In Table 6.2.1, the number
of individuals required to map a QTN with 80% power using association
was calculated assuming r2 of 1 between the marker SNP and QTN. This
assumption is optimistic given the current number of SNPs being used in
genome-wide association studies (typically about 500,000). An r2 of 0.8 between
the QTN and marker SNP seems more likely, and therefore a greater number
of individuals (approximately 1/0.8 more) than that shown in Table 6.2.1 is
currently needed to map a QTN using an association approach. Furthermore,
if the LD structure is taken into account when selecting tagging SNPs, and the
fewest number of SNPs are chosen to tag the entire genome (i.e. there is little or
no redundancy with regard to SNP markers) then genotyping error or failure can
have large impacts on the power to detect association in the given genomic region.
Typically, an association approach is the method of choice to detect common
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variants of small effect, while linkage analysis has more power to detect rare loci
of large effect segregating in large pedigrees. Therefore, the genetic architecture
of the trait must be fully considered when deciding which method, linkage or
association, is likely to be most powerful for a given study. In addition, the
extent of linkage disequilibrium, the basis of association mapping, is much
less than the confidence region surrounding a linkage peak. Therefore, the
resolution of an association is much better than that of linkage (Cardon and
Bell, 2001). Consequently, a greater number of markers are needed to cover a
genetic region when carrying out an association study, and as a result studies
have typically been limited to a few genes or a particular genomic region. Since
the completion of the human genome project (The International Human Genome
Sequencing Consortium, 2001), the mapping of 1.4 million single nucleotide
polymorphisms (SNPs) (The International SNP Map Working Group, 2001),
the ongoing progress of the International HapMap Project (The International
HapMap Consortium, 2003; The International HapMap Consortium, 2005) and
the advent of moderately low-cost, high-throughput genotyping technology,
hypothesis-free genome-wide association (GWA) studies involving hundreds of
thousands of SNPs genotyped on thousands of individuals is now a realistic aim.
Currently, there are almost 12 million confirmed Homo sapien SNPs in dbSNP
(http://www.ncbi.nlm.nih.gov/projects/SNP/, Build 126).
Showing incredible foresight, Risch and Merikangas (1996) proposed a genome-
wide association design long before today’s technology made it a realistic option
for the analysis of complex phenotypes. Many research groups worldwide have
plans to use the method to elucidate polymorphisms underlying variation in
a plethora of human disease phenotypes (Thomas et al., 2005). Results from
initial genome-wide association studies are starting to appear in the literature,
some with encouraging results (Ozaki et al., 2002; Klein et al., 2005; Duerr
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Table 6.2.1: Power to detect QTL using either a linkage or association approach
Phenotypic variance Linkage Association Ratio





0.20 6,832 308 22
0.10 27,480 654 42
0.05 110,060 1,342 82
0.01 2,752,000 6,852 402
N (80% power) gives the number of individuals required to map a QTL with
80% power at a given QTL effect size (calculated using the online GENETIC
POWER CALCULATOR (http://pngu.mgh.harvard.edu/ purcell/gpc/) (Sham
et al., 2000; Purcell et al., 2003)). The linkage power analysis was carried out
assuming a heritability of 50%, and a type I error rate of 0.0001. A sibship study
design was assumed. The association power analysis was carried out assuming
a type I error rate of 0.0000005 (the 95% significance threshold following a
bonferroni correction when testing 1 million SNP markers), a singleton study
design and that the marker and QTN are in perfect linkage disequilibrium (r2 =
1).
et al., 2006; Smyth et al., 2006).
The design and analysis of genome-wide association studies has received much
attention (Cardon and Bell, 2001). Many options are currently available to
researchers in terms of design, including family-based or case-control samples,
map-based or gene-based SNPs, tagging SNPs or randomly placed SNPs, two
stage or one stage studies (Hirschhorn and Daly, 2005). With most studies using
a mixture of these methods, it remains to be seen if one method will stand
out as the most useful. Appropriate correction of multiple testing is vital if
genome-wide association studies are to be interpreted correctly. Furthermore,
the analysis of genome-wide association data needs to account for population
stratification because this is a confounding factor of potentially large effect
(Freedman et al., 2004; Marchini et al., 2004). Further work is needed to iron
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out these design and analysis issues before genome-wide association analysis can
fully take flight.
The efficacy of whole genome association studies for the identification of
polymorphisms underlying complex traits is a controversial issue (Terwilliger
and Hiekkalinna, 2006). Results from candidate gene association studies often
remain unreplicated, and there seems no reason to suggest that the situation will
be different with genome-wide association studies.
Association mapping is based on the linkage disequilibrium between a marker
locus and a quantitative trait nucleotide (QTN). The amount of linkage
disequilibrium between two loci can be quantified using the r2 formula. This
is a function of the allele frequency at the two loci (for example a marker SNP
and a QTN) and the degree of disequilibrium between the alleles. This measure
of linkage disequilibrium is scaled by the allele frequency of the SNP within the
population. The power to detect an association between a given SNP and a QTN
is given by
Power ∝ (r2M,Q)nq2 (6.2.1)
where r2M,Q is the extent of linkage disequilibrium between a marker (M) and
a QTN (Q), n is the sample size and q2 is the proportion of variance explained
by the QTN (Wray, 2005). Therefore, the greater the correlation between the
marker and the QTN (r2) the greater the power to detect association. For a given
amount of LD, r2 can only be maximised when the frequency of the QTN is equal
to that of the marker SNP. Thus, because the current set of marker SNPs have a
minor allele frequency of approximately 5% or more, the success of genome-wide
association studies hangs on the theory that loci underlying complex trait
variation will be common within the population, the common-disease common
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variant hypothesis (Blangero, 2004; Wang et al., 2005; Wray, 2005). There
has been some theoretical and empirical support (Reich and Lander, 2001) for
this theory although others have suggested that a common-disease rare variant
hypothesis is more likely (Pritchard, 2001; Pritchard and Cox, 2002). If the
common-disease rare variant hypothesis is correct then several millions of SNP
markers will be need to be typed across a huge number of individuals to identify
the causal QTNs. For example, Table 6.2.1 shows that 6,852 individuals are
needed to map a QTN that explains 0.01 of the phenotypic variance, assuming
a type I error rate of 5 × 10−7 (the significance level for a Bonferroni correction
following the testing of 1 million SNP markers) and a case-control study design.
However, this number of individuals was calculated assuming that the marker
SNP and the QTN were equally frequent within the population. If the minor
allele frequency of the marker SNP is 0.05 and that of the QTN is 0.01, the
maximum r2 is 0.192 and the sample size required to identify the QTN with
80% power increases to 35,840. Whilst the allelic architecture will vary from
trait to trait, it seems probable that the majority of traits will lie somewhere
between the common-disease common variant and common-disease rare variant
hypotheses and therefore, genomewide association will identify some, but not
all, loci underlying a given complex trait.
There are many potential uses of genome-wide association data beyond simple
association analysis (Gibbs and Singleton, 2006). These other applications
include homozygosity mapping, direct detection of copy number variants
(structural variation), genomic characterization of experimental species and
different human populations, and admixture mapping.
Due to the flexibility of the data, the genome-wide association study is regarded
to be one of the most exciting recent advances in the field. However, with many
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investigators looking at ways to unravel the genetic nature of complex human
phenotypes, new methods and technologies are appearing almost daily. One
method that has caught the attention of many working within the field is the
application and extension of gene expression studies for the analysis of complex
phenotypes (King and Wilson, 1975).
6.2.3 Gene expression studies
The advent of microarray technology allowed large-scale studies of gene
expression to take place (Rockman and Kruglyak, 2006). It can be argued that
this is a more intuitive approach to identifying loci underlying complex trait
variation because phenotypes are directly influenced by the products of genes
(proteins), and only indirectly by the DNA sequence.
Jansen and Nap (2001) suggested an integration of the two approaches, where
the levels of gene expression for multiple genes are treated as a quantitative
trait in a traditional linkage analysis. Brem et al. (2002) were the first to apply
this method, and they identified 570 expression QTL (eQTL) in Saccharomyces
cerevisiae (yeast). Subsequently, many eQTL mapping studies have been carried
out for a wide range of species, with many focussing on the mapping of eQTL
in humans using either a genome-wide linkage (Schadt et al., 2003; Monks
et al., 2004; Morley et al., 2004), or genome-wide association approach (Cheung
et al., 2005; Stranger et al., 2005). With traditional linkage analyses it is the
volume of genetic marker data which makes the analysis difficult. With the
genetic mapping of microarray data it is not only the number of genetic markers
but also the sheer number of expression traits (typically thousands) which
increase the computational intensity of the analysis. To maintain the correct
significance level, a multiple testing correction must be applied that accounts
for both the number of genetic markers and the multiple expression traits
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(Kendziorski and Wang, 2006).
The rationale behind eQTL mapping studies is that the chromosomal region
where sequence variation occurs accounts for some of the variation in the gene
expression. Wayne and McIntyre (2002) carried out a QTL mapping experiment
using Drosophila and subsequently used gene expression microarray technology
to identify candidate genes within the QTL. This method greatly reduces the
number of candidate genes within a given QTL and requires no knowledge on
behalf of the investigator with regard to suitable candidate genes.
The genome-wide mapping of eQTL has the potential to identify gene-gene
interactions, biochemical pathways and enables genetically alike individuals
to be grouped together (Darvasi, 2003). The ability to classify individuals
according to gene expression profiles for a given trait is potentially a significant
step forward in our ability to identify genetically homogeneous subgroups of
individuals or families for genetic linkage and/or association studies. In addition,
gene expression profiles can be used to identify people who would benefit from
a certain treatment and this would be an important step toward personalized
medicines.
A problem associated with the analysis of microarray data is how best to
handle those cases where the probe-set has reached the maximum measurement
threshold. This may occur because a particular gene is been expressed to a high
level, but can also arise due to operator error. Currently, the saturated probe-sets
are removed from the analysis (Wang et al., 2001) but this potentially introduces
a bias and is likely to decrease statistical power. If these saturated chips are
analysed as censored observations within a survival analysis framework, this bias
and loss of power can be reduced. However, the analysis of genome-wide gene
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expression data is already a computationally intensive task and using current
survival analysis methods would significantly increase this. Survival analysis
methods, similar to the linkage method suggested in Chapter 3, need to be
developed which are computationally simple, thus enabling them to be applied
to genome-wide gene expression data. These computationally simple methods
would also be of benefit when analysing survival phenotypes using traditional
genome-wide association or linkage data.
6.3 Conclusions
The use of age at onset data to identify loci underlying complex traits is an ever
expanding field. The survival analysis methods which are used to analyse genetic
data need to be modified to cope with the sheer volumes of data being generated
in modern genetic studies. The incorporation of computationally efficient
survival analysis methods into widely used genome analysis packages, such as
MERLIN or SOLAR (Abecasis et al., 2002; Duggirala et al., 1997; Almasy and
Blangero, 1998), would lead to an increase in the use of age at onset data. In
an attempt to obtain a homogeneous sample of individuals for genetic analysis,
more and more investigators will be using the age at onset of disease as a defining
characteristic. Age at onset data has already proved the key to the identification
of loci underlying several traits, both Mendelian and complex, and this seems
set to continue.
Despite a few false dawns, the mapping of loci underlying complex traits is
now a distinct possibility. Over the next five years we should see an increasing
number of complex trait loci identified. By using linkage analysis to analyse
families segregating narrowly-defined subsets of a disease, rare loci of large effect
will be identified for many complex traits. The huge amount of phenotypic
131
information held on hundreds of thousands of individuals in population biobanks
will enable large-scale genetic studies of complex traits and this should lead
to the identification of many loci of medium effect size. The continued
success of genome-wide association analysis will identify many of the common
polymorphisms of medium to large effect which underpin complex trait variation.
The recent advent of genome-wide gene expression data allows a more direct link
between genotype and phenotype. The identification of eQTL that have different
levels of expression in affected and unaffected individuals presents a new and
exciting opportunity to identify loci underlying variation in complex traits.
There are still many obstacles to overcome. Methods need to be developed
for including gene-gene and gene-environment interactions into gene mapping
studies. The trend in genetics is to discount the environmental component
of variation as if it were a stand alone component of variation outside of our
interest (Hemminki et al., 2006). However, as geneticists we should be paying
great attention to environmental variation because of its interaction with genetic
factors. If gene-gene and gene-environment interactions are to be successfully
identified then we will need very large sample sizes, perhaps even bigger than
those available in most biobanks. The release of genetic data into the public
domain could create massive samples of phenotypically similar individuals. The
Genetic Association Information Network (http://www.fnih.org/GAIN/) and
The Wellcome Trust Case Control Consortium (http://www.wtccc.org.uk) have
already committed themselves to the conditional public release of data. However,
there are many ethical, political and legal issues to overcome before this becomes
widespread.
Many geneticists are focussing on the problem of identifying the QTN of small
effect which underlie variation in complex traits. These QTL are extremely
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difficult to map using either a linkage or association approach, and the sample
sizes required to map such loci are almost incomprehensible. However, whilst the
identification of these small effect QTN may aid our understanding of the biology
underlying the trait, these QTN will have little impact on an individual’s risk
of disease. Therefore, in terms of personalized medicine and the identification
of people at high risk of common diseases, these loci are of little use. The only
loci of real predictive value individually are those that confer a reasonable risk of
disease, and it seems probable that these will be identified in the coming years.
Therefore, the promised land of personalized medicine is perhaps not as far away
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